10-Q

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-Q

þ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934
FOR THE QUARTERLY PERIOD ENDED SEPTEMBER 30, 2015
	OR
o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934
FOR THE TRANSITION PERIOD FROM ______________TO_______________

Commission File Number: 001-00652

UNIVERSAL CORPORATION

(Exact name of registrant as specified in its charter)

Virginia (State or other jurisdiction of incorporation or organization)	54-0414210 (I.R.S. Employer Identification Number)
9201 Forest Hill Avenue, Richmond, Virginia (Address of principal executive offices)	23235 (Zip Code)

804-359-9311

(Registrant's telephone number, including area code)

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.    Yes þNo o

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes þNo o

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See definitions of “large accelerated filer,” “accelerated filer,” and “smaller reporting company” in Rule 12b-2 of the Exchange Act. (Check one):

Large accelerated filer þ Accelerated filer o Non-accelerated filer o Smaller reporting company o

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes o No þ

As of October 30, 2015, the total number of shares of common stock outstanding was 22,717,448.

UNIVERSAL CORPORATION

FORM 10-Q

TABLE OF CONTENTS

Item No.		Page
	PART I - FINANCIAL INFORMATION
1.	Financial Statements	3
2.	Management's Discussion and Analysis of Financial Condition and Results of Operations	23
3.	Quantitative and Qualitative Disclosures About Market Risk	28
4.	Controls and Procedures	29
	PART II - OTHER INFORMATION
1.	Legal Proceedings	30
1A.	Risk Factors	30
2.	Unregistered Sales of Equity Securities and Use of Proceeds	30
6.	Exhibits	31
	Signatures	32

2

PART I. FINANCIAL INFORMATION

ITEM 1. FINANCIAL STATEMENTS

UNIVERSAL CORPORATION

CONSOLIDATED STATEMENTS OF INCOME AND COMPREHENSIVE INCOME

(in thousands, except share and per share data)

	Three Months Ended September 30,						Six Months Ended September 30,
	2015			2014			2015			2014
	(Unaudited)						(Unaudited)
Sales and other operating revenues	$	456,382		$	464,116		$	731,801		$	735,588
Costs and expenses
Cost of goods sold	358,288			379,045			585,318			594,977
Selling, general and administrative expenses	60,810			59,809			112,106			123,586
Restructuring and impairment costs	—			3,350			2,389			3,350
Operating income	37,284			21,912			31,988			13,675
Equity in pretax earnings of unconsolidated affiliates	846			3,317			230			3,918
Interest income	205			67			444			210
Interest expense	3,912			4,852			7,796			8,872
Income before income taxes	34,423			20,444			24,866			8,931
Income tax expense (benefit)	9,359			4,960			5,927			(7,078		)
Net income	25,064			15,484			18,939			16,009
Less: net income attributable to noncontrolling interests in subsidiaries	(2,599		)	(459		)	(2,421		)	(267		)
Net income attributable to Universal Corporation	22,465			15,025			16,518			15,742
Dividends on Universal Corporation convertible perpetual preferred stock	(3,687		)	(3,713		)	(7,374		)	(7,425		)
Earnings available to Universal Corporation common shareholders	$	18,778		$	11,312		$	9,144		$	8,317
Earnings per share attributable to Universal Corporation common shareholders:
Basic	$	0.83		$	0.49		$	0.40		$	0.36
Diluted	$	0.81		$	0.48		$	0.40		$	0.35
Weighted average common shares outstanding:
Basic	22,675,323			23,178,082			22,649,270			23,200,589
Diluted	27,850,628			23,508,527			22,936,631			23,521,571
Total comprehensive income, net of income taxes	$	19,470		$	4,954		$	21,850		$	6,303
Less: comprehensive (income) loss attributable to noncontrolling interests, net of income taxes	(2,259		)	(178		)	(1,995		)	(230		)
Comprehensive income attributable to Universal Corporation, net of income taxes	$	17,211		$	4,776		$	19,855		$	6,073
Dividends declared per common share	$	0.52		$	0.51		$	1.04		$	1.02

See accompanying notes.

3

UNIVERSAL CORPORATION     

CONSOLIDATED BALANCE SHEETS

(in thousands of dollars)

	September 30,			September 30,			March 31,
	2015			2014			2015
	(Unaudited)			(Unaudited)
ASSETS
Current assets
Cash and cash equivalents	$	68,970		$	29,567		$	248,783
Accounts receivable, net	303,963			290,162			434,362
Advances to suppliers, net	40,627			70,296			114,883
Accounts receivable—unconsolidated affiliates	59,370			98,707			1,907
Inventories—at lower of cost or market:
Tobacco	999,312			1,164,293			636,488
Other	85,222			100,516			62,195
Prepaid income taxes	19,779			28,138			17,811
Deferred income taxes	31,491			34,560			36,611
Other current assets	75,122			83,754			81,570
Total current assets	1,683,856			1,899,993			1,634,610
Property, plant and equipment
Land	16,583			17,022			16,790
Buildings	252,153			239,568			238,372
Machinery and equipment	585,466			577,064			576,010
	854,202			833,654			831,172
Less: accumulated depreciation	(539,749		)	(528,722		)	(525,783		)
	314,453			304,932			305,389
Other assets
Goodwill and other intangibles	99,049			99,291			99,146
Investments in unconsolidated affiliates	79,995			88,841			76,512
Deferred income taxes	20,661			18,861			6,301
Other noncurrent assets	55,976			68,973			76,515
	255,681			275,966			258,474
Total assets	$	2,253,990		$	2,480,891		$	2,198,473

See accompanying notes.

4

UNIVERSAL CORPORATION     

CONSOLIDATED BALANCE SHEETS

(in thousands of dollars)

	September 30,			September 30,			March 31,
	2015			2014			2015
	(Unaudited)			(Unaudited)
LIABILITIES AND SHAREHOLDERS’ EQUITY
Current liabilities
Notes payable and overdrafts	$	86,095		$	359,349		$	59,862
Accounts payable and accrued expenses	155,824			154,826			140,112
Accounts payable—unconsolidated affiliates	98			1,150			3,281
Customer advances and deposits	67,100			57,723			30,183
Accrued compensation	18,423			20,272			28,232
Income taxes payable	5,612			11,164			9,243
Current portion of long-term obligations	—			118,750			—
Total current liabilities	333,152			723,234			270,913
Long-term obligations	370,000			230,000			370,000
Pensions and other postretirement benefits	93,588			74,975			97,048
Other long-term liabilities	37,472			34,567			36,790
Deferred income taxes	32,067			39,235			26,628
Total liabilities	866,279			1,102,011			801,379
Shareholders’ equity
Universal Corporation:
Preferred stock:
Series A Junior Participating Preferred Stock, no par value, 500,000 shares authorized, none issued or outstanding	—			—			—
Series B 6.75% Convertible Perpetual Preferred Stock, no par value, 220,000 shares authorized, 218,490 shares issued and outstanding (219,999 at September 30, 2014 and 218,490 at March 31, 2015)	211,562			213,023			211,562
Common stock, no par value, 100,000,000 shares authorized, 22,680,233 shares issued and outstanding (23,183,259 at September 30, 2014, and 22,593,266 at March 31, 2015)	207,349			207,552			206,002
Retained earnings	1,005,353			971,391			1,020,155
Accumulated other comprehensive loss	(71,657		)	(44,001		)	(74,994		)
Total Universal Corporation shareholders' equity	1,352,607			1,347,965			1,362,725
Noncontrolling interests in subsidiaries	35,104			30,915			34,369
Total shareholders' equity	1,387,711			1,378,880			1,397,094
Total liabilities and shareholders' equity	$	2,253,990		$	2,480,891		$	2,198,473

See accompanying notes.

5

UNIVERSAL CORPORATION     

CONSOLIDATED STATEMENTS OF CASH FLOWS

(in thousands of dollars)

	Six Months Ended September 30,
	2015			2014
	(Unaudited)
CASH FLOWS FROM OPERATING ACTIVITIES:
Net income	$	18,939		$	16,009
Adjustments to reconcile net income to net cash used by operating activities:
Depreciation	18,362			17,298
Amortization	446			816
Net provision for losses (recoveries) on advances and guaranteed loans to suppliers	(4,354		)	(2,497		)
Foreign currency remeasurement loss (gain), net	21,981			7,156
Restructuring and impairment costs	2,389			3,350
Other, net	481			(9,470		)
Changes in operating assets and liabilities, net	(202,046		)	(386,404		)
Net cash used by operating activities	(143,802		)	(353,742		)
CASH FLOWS FROM INVESTING ACTIVITIES:
Purchase of property, plant and equipment	(28,457		)	(30,571		)
Proceeds from sale of property, plant and equipment	1,155			983
Net cash used by investing activities	(27,302		)	(29,588		)
CASH FLOWS FROM FINANCING ACTIVITIES:
Issuance (repayment) of short-term debt, net	23,826			297,507
Repayment of long-term obligations	—			(7,500		)
Dividends paid to noncontrolling interests	(1,260		)	(1,977		)
Issuance of common stock	—			187
Repurchase of common stock	—			(7,202		)
Dividends paid on convertible perpetual preferred stock	(7,374		)	(7,425		)
Dividends paid on common stock	(23,536		)	(23,661		)
Net cash provided (used) by financing activities	(8,344		)	249,929
Effect of exchange rate changes on cash	(365		)	(564		)
Net decrease in cash and cash equivalents	(179,813		)	(133,965		)
Cash and cash equivalents at beginning of year	248,783			163,532
Cash and cash equivalents at end of period	$	68,970		$	29,567

See accompanying notes.

6

UNIVERSAL CORPORATION

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

NOTE 1.   BASIS OF PRESENTATION

Universal Corporation, which together with its subsidiaries is referred to herein as “Universal” or the “Company,” is the leading global leaf tobacco supplier. Because of the seasonal nature of the Company’s business, the results of operations for any fiscal quarter will not necessarily be indicative of results to be expected for other quarters or a full fiscal year. All adjustments necessary to state fairly the results for the period have been included and were of a normal recurring nature. Certain amounts in prior year statements have been reclassified to conform to the current year presentation. This Form 10-Q should be read in conjunction with the financial statements and notes thereto included in the Company’s Annual Report on Form 10-K for the fiscal year ended March 31, 2015.

NOTE 2.   ACCOUNTING PRONOUNCEMENTS

In May 2014, the Financial Accounting Standards Board ("FASB") issued Accounting Standards Update No. 2014-09, “Revenue from Contracts with Customers” (“ASU 2014-09”), which supersedes substantially all of the current revenue recognition guidance under U.S. generally accepted accounting principles (“U.S. GAAP”).  ASU 2014-09 was developed under a joint project with the International Accounting Standards Board (“IASB”) to improve and converge the existing revenue recognition accounting guidance in U.S. GAAP and International Accounting Standards.  Under ASU 2014-09, the central underlying principle is to recognize revenues when promised goods or services are transferred to customers at an amount determined by the consideration a company expects to receive for those goods or services.  The guidance outlines a five-step process for determining the amount and timing of revenue to be recognized from those arrangements.  It is more principles-based than the existing guidance under U.S. GAAP, and therefore is expected to require more management judgment and involve more estimates than the current guidance.  ASU 2014-09 is effective for annual periods beginning after December 15, 2017, including all interim periods within the year of adoption. Companies are allowed to select between two transition methods:  (1) a full retrospective transition method with the application of the new guidance to each prior reporting period presented, or (2) a retrospective transition method that recognizes the cumulative effect on prior periods at the date of adoption together with additional footnote disclosures.  Universal expects to adopt ASU 2014-09 effective April 1, 2018, which is the beginning of the fiscal year ending March 31, 2019.  The Company is currently evaluating the impact that the adoption of ASU 2014-09 will have on its consolidated financial statements and has not made any decision on the method of adoption.

In April 2015, the FASB issued Accounting Standards Update No. 2015-03, “Simplifying the Presentation of Debt Issuance Costs” (“ASU 2015-03”). ASU 2015-03 requires that debt issuance costs related to a recognized debt liability be presented in the balance sheet as a direct deduction from the carrying amount of that debt liability, consistent with debt discounts. ASU 2015-03 is effective for fiscal years beginning after December 31, 2015. The Company will make the required balance sheet presentation change upon adoption of ASU 2015-03 effective for the quarter ending June 30, 2016, which is the first quarter of the fiscal year ending March 31, 2017.

In July 2015, the FASB issued Accounting Standards Update No. 2015-11, “Simplifying the Measurement of Inventory” (“ASU 2015-11”). ASU 2015-11 requires that most inventory be measured at the lower of cost and net realizable value. ASU 2015-11 defines net realizable value as the "estimated selling price in the ordinary course of business, less reasonable predictable costs of completion, disposal, and transportation." ASU 2015-011 is effective for fiscal years beginning after December 31, 2016. The Company is currently evaluating the impact that the adoption of ASU 2015-11 will have on its consolidated financial statements. ASU 2015-11 will be applied prospectively after the date of adoption, as required by the guidance.

NOTE 3.   GUARANTEES, OTHER CONTINGENT LIABILITIES, AND OTHER MATTERS

Guarantees and Other Contingent Liabilities

Guarantees of Bank Loans and Other Contingent Liabilities

Guarantees of bank loans to tobacco growers for crop financing and construction of curing barns or other tobacco producing assets have long been industry practice in Brazil and support the farmers’ production of tobacco there. At September 30, 2015, the Company’s total exposure under guarantees issued by its operating subsidiary for banking facilities of farmers in Brazil was approximately $25 million ($26 million face amount including unpaid accrued interest, less $1 million recorded for the fair value of the guarantees). All of these guarantees expire within one year. The subsidiary withholds payments due to the farmers on delivery

7

of tobacco and forwards those payments to the third-party banks. Failure of farmers to deliver sufficient quantities of tobacco to the subsidiary to cover its obligations to the third-party banks could result in a liability for the subsidiary under the related guarantees; however, in that case, the subsidiary would have recourse against the farmers. The maximum potential amount of future payments that the Company’s subsidiary could be required to make at September 30, 2015, was the face amount, $26 million including unpaid accrued interest ($35 million at September 30, 2014, and $17 million at March 31, 2015). The fair value of the guarantees was a liability of approximately $1 million at September 30, 2015 ($2 million at September 30, 2014, and $2 million at March 31, 2015). In addition to these guarantees, the Company has other contingent liabilities, primarily related to outstanding letters of credit, totaling approximately $3 million at September 30, 2015.

Value-Added Tax Assessments in Brazil

As further discussed below, the Company’s local operating subsidiaries pay significant amounts of value-added tax (“VAT”) in connection with their normal operations. In Brazil, VAT is assessed at the state level when green tobacco is transferred between states. The Company’s operating subsidiary there pays VAT when tobaccos grown in the states of Santa Catarina and Parana are transferred to its factory in the state of Rio Grande do Sul for processing. The subsidiary has received assessments for additional VAT plus interest and penalties from tax authorities for the states of Santa Catarina and Parana based on audits of the subsidiary’s VAT filings for specified periods. In June 2011, tax authorities for the state of Santa Catarina issued assessments for tax, interest, and penalties for periods from 2006 through 2009 totaling approximately $12 million. In September 2014, tax authorities for the state of Parana issued an assessment for tax, interest, and penalties for periods from 2009 through 2014 totaling approximately $14 million. Those amounts are based on the exchange rate for the Brazilian currency at September 30, 2015. Management of the operating subsidiary and outside counsel believe that errors were made by the tax authorities for both states in determining all or significant portions of these assessments and that various defenses support the subsidiary’s positions.

With respect to the Santa Catarina assessments, the subsidiary took appropriate steps to contest the full amount of the claims. As of September 30, 2015, a portion of the subsidiary’s arguments had been accepted, and the outstanding assessment had been reduced. The reduced assessment, together with the related accumulated interest through the end of the current reporting period, totaled approximately $10 million (at the September 30, 2015 exchange rate). The subsidiary is continuing to contest the full remaining amount of the assessment. While the range of reasonably possible loss is zero up to the full $10 million remaining assessment, based on the strength of the subsidiary’s defenses, no loss within that range is considered probable at this time and no liability has been recorded at September 30, 2015.

With respect to the Parana assessment, management of the subsidiary and outside counsel have undertaken the steps required to contest the full amount of the claim. A significant portion of the Parana assessment is based on positions taken by the tax authorities that management and outside counsel believe deviate significantly from the underlying statutes and relevant case law. In addition, under the law, the subsidiary’s tax filings for certain periods covered in the assessment were no longer open to any challenge by the tax authorities. On that basis, the range of reasonably possible loss is considered to be zero up to a maximum of $12 million (including accumulated interest), rather than the full amount of the assessment. Based on the strength of the subsidiary's defenses, no loss within that range is considered probable at this time and no liability has been recorded at September 30, 2015.

In both states, the process for reaching a final resolution to the assessments is expected to be lengthy, and management is not currently able to predict when either case will be concluded. Should the subsidiary ultimately be required to pay any tax, interest, or penalties in either case, the portion paid for tax would generate value-added tax credits that the subsidiary may be able to recover.

Other Legal and Tax Matters

Various subsidiaries of the Company are involved in other litigation and tax examinations incidental to their business activities.  While the outcome of these matters cannot be predicted with certainty, management is vigorously defending the matters and does not currently expect that any of them will have a material adverse effect on the Company’s business or financial position.  However, should one or more of these matters be resolved in a manner adverse to management’s current expectation, the effect on the Company’s results of operations for a particular fiscal reporting period could be material.

Advances to Suppliers

In many sourcing origins where the Company operates, it provides agronomy services and seasonal advances of seed, fertilizer, and other supplies to tobacco farmers for crop production, or makes seasonal cash advances to farmers for the procurement of those inputs. These advances are short term, are repaid upon delivery of tobacco to the Company, and are reported in advances to suppliers in the consolidated balance sheets. In several origins, the Company has made long-term advances to tobacco farmers to finance curing barns and other farm infrastructure. In some years, due to low crop yields and other factors, individual farmers may not deliver sufficient volumes of tobacco to fully repay their seasonal advances, and the Company may extend repayment of those advances into future crop years. The long-term portion of advances is included in other noncurrent assets in the consolidated

8

balance sheets. Both the current and the long-term portions of advances to suppliers are reported net of allowances recorded when the Company determines that amounts outstanding are not likely to be collected. Short-term and long-term advances to suppliers totaled $71 million at September 30, 2015, $115 million at September 30, 2014, and $156 million at March 31, 2015. The related valuation allowances totaled $27 million at September 30, 2015, $38 million at September 30, 2014, and $35 million at March 31, 2015, and were estimated based on the Company’s historical loss information and crop projections. The allowances were reduced by net recoveries of approximately $4 million and $2 million in the six-month periods ended September 30, 2015 and 2014, respectively. These net recoveries are included in selling, general, and administrative expenses in the consolidated statements of income. Interest on advances is recognized in earnings upon the farmers’ delivery of tobacco in payment of principal and interest.

Recoverable Value-Added Tax Credits

In many foreign countries, the Company’s local operating subsidiaries pay significant amounts of value-added tax (“VAT”) on purchases of unprocessed and processed tobacco, crop inputs, packing materials, and various other goods and services. In some countries, VAT is a national tax, and in other countries it is assessed at the state level. Items subject to VAT vary from jurisdiction to jurisdiction, as do the rates at which the tax is assessed. When tobacco is sold to customers in the country of origin, the operating subsidiaries generally collect VAT on those sales. The subsidiaries are normally permitted to offset their VAT payments against the collections and remit only the incremental VAT collections to the tax authorities. When tobacco is sold for export, VAT is normally not assessed. In countries where tobacco sales are predominately for export markets, VAT collections generated on downstream sales are often not sufficient to fully offset the subsidiaries’ VAT payments. In those situations, unused VAT credits can accumulate. Some jurisdictions have procedures that allow companies to apply for refunds of unused VAT credits from the tax authorities, but the refund process often takes an extended period of time and it is not uncommon for refund applications to be challenged or rejected in part on technical grounds. Other jurisdictions may permit companies to sell or transfer unused VAT credits to third parties in private transactions, although approval for such transactions must normally be obtained from the tax authorities, limits on the amounts that can be transferred may be imposed, and the proceeds realized may be heavily discounted from the face value of the credits. Due to these factors, local operating subsidiaries in some countries can accumulate significant balances of VAT credits over time. The Company reviews these balances on a regular basis and records valuation allowances on the credits to reflect amounts that are not expected to be recovered, as well as discounts anticipated on credits that are expected to be sold or transferred. At September 30, 2015, the aggregate balance of recoverable tax credits held by the Company’s subsidiaries totaled approximately $52 million ($69 million at September 30, 2014, and $60 million at March 31, 2015), and the related valuation allowances totaled approximately $21 million ($37 million at September 30, 2014, and $23 million at March 31, 2015). The net balances are reported in other current assets and other noncurrent assets in the consolidated balance sheets.

NOTE 4.   RESTRUCTURING AND IMPAIRMENT COSTS

Universal continually reviews its business for opportunities to realize efficiencies, reduce costs, and realign its operations in response to business changes. Restructuring and impairment costs are periodically incurred in connection with those activities.     For the reporting periods ended September 30, 2015 and 2014, all restructuring costs incurred related to operations that are part of the Other Regions reportable segment of the Company's Flue-Cured and Burley Tobacco Operations.

Six Months Ended September 30, 2015

In the first quarter of fiscal year 2016, the Company recorded restructuring and impairment costs totaling $2.4 million related to plans to significantly scale back its operations in Zambia. Those costs included statutory employee termination benefits, impairment charges related to outstanding balances on loans to farmers whose contracts were terminated as a result of the decision, and impairment charges on certain property and equipment. The total restructuring liability related to these costs at September 30, 2015, was $1.6 million, the majority of which the Company expects will be paid before the end of the current fiscal year.

Three andSix Months Ended September 30, 2014

In the second quarter of fiscal year 2015, the Company announced plans to suspend its operations in Argentina. In connection with that decision, during the quarter ended September 30, 2014, the Company's subsidiary in Argentina incurred costs related to employee terminations, as well as costs related to exiting its business arrangements with a supplier. Substantially all operations in Argentina were discontinued effective December 31, 2014. The Company also initiated and completed a program to downsize certain functions at its operations in Brazil during the quarter and recorded employee termination costs in connection with that initiative. Restructuring costs recorded in Argentina and Brazil totaled approximately $3.4 million on a consolidated basis, all of which was paid by the end of fiscal year 2015.

9

NOTE 5.   EARNINGS PER SHARE

The following table sets forth the computation of basic and diluted earnings per share:

	Three Months Ended September 30,						Six Months Ended September 30,
(in thousands, except share and per share data)	2015			2014			2015			2014
Basic Earnings Per Share
Numerator for basic earnings per share
Net income attributable to Universal Corporation	$	22,465		$	15,025		$	16,518		$	15,742
Less: Dividends on convertible perpetual preferred stock	(3,687		)	(3,713		)	(7,374		)	(7,425		)
Earnings available to Universal Corporation common shareholders for calculation of basic earnings per share	18,778			11,312			9,144			8,317
Denominator for basic earnings per share
Weighted average shares outstanding	22,675,323			23,178,082			22,649,270			23,200,589
Basic earnings per share	$	0.83		$	0.49		$	0.40		$	0.36
Diluted Earnings Per Share
Numerator for diluted earnings per share
Earnings available to Universal Corporation common shareholders	$	18,778		$	11,312		$	9,144		$	8,317
Add: Dividends on convertible perpetual preferred stock (if conversion assumed)	3,687			—			—			—
Earnings available to Universal Corporation common shareholders for calculation of diluted earnings per share	22,465			11,312			9,144			8,317
Denominator for diluted earnings per share
Weighted average shares outstanding	22,675,323			23,178,082			22,649,270			23,200,589
Effect of dilutive securities (if conversion or exercise assumed)
Convertible perpetual preferred stock	4,848,766			—			—			—
Employee share-based awards	326,539			330,445			287,361			320,982
Denominator for diluted earnings per share	27,850,628			23,508,527			22,936,631			23,521,571
Diluted earnings per share	$	0.81		$	0.48		$	0.40		$	0.35

For the six months ended September 30, 2015 and the three- and six-month periods ended September 30, 2014, conversion of the Company's outstanding Series B 6.75% Convertible Perpetual Preferred Stock was not assumed since the effects would have been antidilutive. The Company had the following potentially dilutive securities (stock appreciation rights) outstanding for the six months ended September 30, 2015 and 2014 that were not included in the computation of diluted earnings per share because their exercise price exceeded the market price of the Company's common stock, and thus their effect would have been antidilutive:

	Six Months Ended September 30,
	2015		2014
Potentially dilutive securities	133,600		169,000
Weighted-average exercise price	$	62.66	$	62.66

10

NOTE 6.   INCOME TAXES

The Company is subject to the tax laws of many jurisdictions. Changes in tax laws or the interpretation of tax laws can affect the Company’s earnings, as can the resolution of pending and contested tax issues. The Company's consolidated effective income tax rate on pretax earnings is affected by a number of factors, including the mix of domestic and foreign earnings, the effect of exchange rate changes on deferred taxes, and the Company’s ability to utilize foreign tax credits.

The consolidated effective income tax rate was approximately 27% for the quarter ended September 30, 2015, compared to 24% for the quarter ended September 30, 2014. The effective rate for both quarters was lower than the 35% U.S. federal statutory rate, primarily due to a lower effective tax rate on dividend income from unconsolidated operations, as well as the effect of changes in exchange rates on deferred income tax assets and liabilities of foreign subsidiaries. The reduction in the effective rate created by those items was more significant for the quarter ended September 30, 2014, primarily because pretax earnings were lower for that period.

The comparison of the consolidated effective income tax rates for the six-month periods ended September 30, 2015 and 2014 is affected by an income tax benefit of $8 million recorded in the prior year period, arising from the ability of a subsidiary to pay a significant portion of a fine and related interest charges that were settled during that period following the unsuccessful appeal of a case involving anti-competitive activities in the Italian tobacco market. Although the portion of the fine paid by the subsidiary was not deductible for income tax purposes in its local tax jurisdiction, it reduced the subsidiary’s cumulative undistributed earnings and the associated consolidated tax liability, resulting in the $8 million benefit in the Company’s consolidated income tax provision. Excluding this discrete item in the prior year, the consolidated effective income tax rate was 24% for the six months ended September 30, 2015, compared to 10% for the six months ended September 30, 2014. The effective tax rates for both periods benefited from the lower effective tax rate on dividend income from unconsolidated operations and from the effect of exchange rate changes on deferred income tax assets and liabilities; however, the effect of those items was more significant for the six months ended September 30, 2014 due to the lower pretax earnings for that period.

NOTE 7.   DERIVATIVES AND HEDGING ACTIVITIES

Universal is exposed to various risks in its worldwide operations and uses derivative financial instruments to manage two specific types of risks – interest rate risk and foreign currency exchange rate risk. Interest rate risk is managed by entering into interest rate swap agreements, and foreign currency exchange rate risk is managed by entering into forward foreign currency exchange contracts. However, the Company’s policy also permits other types of derivative instruments. In addition, foreign currency exchange rate risk is also managed through strategies that do not involve derivative instruments, such as using local borrowings and other approaches to minimize net monetary positions in non-functional currencies. The disclosures below provide additional information about the Company’s hedging strategies, the derivative instruments used, and the effects of these activities on the consolidated statements of income and the consolidated balance sheets. In the consolidated statements of cash flows, the cash flows associated with all of these activities are reported in net cash provided by operating activities.

Hedging Strategy for Interest Rate Risk

In January 2015, the Company entered into receive-floating/pay-fixed interest rate swap agreements that were designated and qualified as hedges of the exposure to changes in interest payment cash flows created by fluctuations in variable interest rates on two outstanding non-amortizing bank term loans that were funded as part of a new bank credit facility in December 2014. Although no significant ineffectiveness is expected with this hedging strategy, the effectiveness of the interest rate swaps is evaluated on a quarterly basis. At September 30, 2015, the total notional amount of the interest rate swaps was $370 million, which corresponded with the aggregate outstanding balance of the term loans.

Previously, the Company had receive-floating/pay-fixed interest rate swap agreements that were designated and qualified as cash flow hedges on an amortizing bank term loan that was repaid concurrent with closing on the new bank credit facility. Those swap agreements, which had an aggregate notional amount of approximately $74 million reflecting the principal balance outstanding on the loan, were terminated upon repayment of the debt in December 2014.

Cash Flow Hedging Strategy for Foreign Currency Exchange Rate Risk Related to Forecast Purchases of Tobacco and Related Processing Costs

The majority of the tobacco production in most countries outside the United States where Universal operates is sold in export markets at prices denominated in U.S. dollars. However, purchases of tobacco from farmers and most processing costs (such as labor and energy) in those countries are usually denominated in the local currency. Changes in exchange rates between the U.S. dollar and the local currencies where tobacco is grown and processed affect the ultimate U.S. dollar cost of the processed tobacco. From time to time, the Company enters into forward contracts to sell U.S. dollars and buy the local currency at future dates that

11

coincide with the expected timing of a portion of the tobacco purchases and processing costs. This strategy offsets the variability of future U.S. dollar cash flows for tobacco purchases and processing costs for the foreign currency notional amount hedged. This hedging strategy has been used mainly for tobacco purchases and processing costs in Brazil. The aggregate U.S. dollar notional amount of forward contracts entered for these purposes during the first six months of fiscal years 2016 and 2015, was as follows:

	Six Months Ended September 30,
(in millions of dollars)	2015		2014
Tobacco purchases	$	19.8	$	53.8
Processing costs	5.6		12.3
Total	$	25.4	$	66.1

All contracts related to tobacco purchases were designated and qualify as hedges of the future cash flows associated with the forecast purchases of tobacco. As a result, except for amounts related to any ineffective portion of the hedging strategy or any early de-designation of the hedge arrangement, changes in fair values of the forward contracts have been recognized in comprehensive income as they occurred, but only recognized in earnings upon sale of the related tobacco to third-party customers. Forward contracts related to processing costs have not been designated as hedges, and gains and losses on those contracts have been recognized in earnings on a mark-to-market basis.

Purchases of the 2015 crop in Brazil were completed in August 2015, and all forward contracts to hedge those purchases matured and settled by that time. For substantially all hedge gains and losses recorded in accumulated other comprehensive loss at September 30, 2015, the Company expects to complete the sale of the tobacco and recognize the amounts in earnings during fiscal year 2016.

Hedging Strategy for Foreign Currency Exchange Rate Risk Related to Net Local Currency Monetary Assets and Liabilities of Foreign Subsidiaries

Most of the Company’s foreign subsidiaries transact the majority of their sales in U.S. dollars and finance the majority of their operating requirements with U.S. dollar borrowings, and therefore use the U.S. dollar as their functional currency. These subsidiaries normally have certain monetary assets and liabilities on their balance sheets that are denominated in the local currency. Those assets and liabilities can include cash and cash equivalents, accounts receivable and accounts payable, advances to farmers and suppliers, deferred income tax assets and liabilities, recoverable value-added taxes, and other items. Net monetary assets and liabilities denominated in the local currency are remeasured into U.S. dollars each reporting period, generating gains and losses that the Company records in earnings as a component of selling, general, and administrative expenses. The level of net monetary assets or liabilities denominated in the local currency normally fluctuates throughout the year based on the operating cycle, but it is most common for monetary assets to exceed monetary liabilities, sometimes by a significant amount. When this situation exists and the local currency weakens against the U.S. dollar, remeasurement losses are generated. Conversely, remeasurement gains are generated on a net monetary asset position when the local currency strengthens against the U.S. dollar. To manage a portion of its exposure to currency remeasurement gains and losses, the Company enters into forward contracts to buy or sell the local currency at future dates coinciding with expected changes in the overall net local currency monetary asset position of the subsidiary. Gains and losses on the forward contracts are recorded in earnings as a component of selling, general, and administrative expenses for each reporting period as they occur, and thus directly offset the related remeasurement losses or gains in the consolidated statements of income for the notional amount hedged. The Company does not designate these contracts as hedges for accounting purposes. The contracts are generally arranged to hedge the subsidiary's projected exposure to currency remeasurement risk for specified periods of time, and new contracts are entered as necessary throughout the year to replace previous contracts as they mature. The Company is currently using forward currency contracts to manage its exposure to currency remeasurement risk in Brazil. The total notional amounts of contracts outstanding at September 30, 2015 and 2014, and March 31, 2015, were approximately $114.0 million, $89.8 million, and $80.4 million, respectively. To further mitigate currency remeasurement exposure, the Company’s foreign subsidiaries may utilize short-term local currency financing during certain periods. This strategy, while not involving the use of derivative instruments, is intended to minimize the subsidiary’s net monetary position by financing a portion of the local currency monetary assets with local currency monetary liabilities and thus hedging a portion of the overall position.

Several of the Company’s foreign subsidiaries transact the majority of their sales and finance the majority of their operating requirements in their local currency, and therefore use their respective local currencies as the functional currency for reporting purposes. From time to time, these subsidiaries sell tobacco to customers in transactions that are not denominated in the functional currency. In those situations, the subsidiaries routinely enter into forward exchange contracts to offset currency risk for the period

12

of time that a fixed-price order and the related trade account receivable are outstanding with the customer. The contracts are not designated as hedges for accounting purposes.

Effect of Derivative Financial Instruments on the Consolidated Statements of Income

The table below outlines the effects of the Company’s use of derivative financial instruments on the consolidated statements of income for the three- and six-month periods ended September 30, 2015 and 2014:

	Three Months Ended September 30,						Six Months Ended September 30,
(in thousands of dollars)	2015			2014			2015			2014
Cash Flow Hedges - Interest Rate Swap Agreements
Derivative
Effective Portion of Hedge
Gain (loss) recorded in accumulated other comprehensive loss	$	(9,732	)	$	50		$	(6,056	)	$	(109	)
Gain (loss) reclassified from accumulated other comprehensive loss into earnings	$	(1,341	)	$	(199	)	$	(2,676	)	$	(406	)
Location of gain (loss) reclassified from accumulated other comprehensive loss into earnings	Interest expense
Ineffective Portion of Hedge
Gain (loss) recognized in earnings	$	—		$	—		$	—		$	—
Location of gain (loss) recognized in earnings	Selling, general and administrative expenses
Hedged Item
Description of hedged item	Floating rate interest payments on term loan
Cash Flow Hedges - Forward Foreign Currency Exchange Contracts
Derivative
Effective Portion of Hedge
Gain (loss) recorded in accumulated other comprehensive loss	$	101		$	47		$	1,283		$	1,700
Gain (loss) reclassified from accumulated other comprehensive loss into earnings	$	344		$	1,208		$	358		$	1,459
Location of gain (loss) reclassified from accumulated other comprehensive loss into earnings	Cost of goods sold
Ineffective Portion and Early De-designation of Hedges
Gain (loss) recognized in earnings	$	(673	)	$	30		$	745		$	257
Location of gain (loss) recognized in earnings	Selling, general and administrative expenses
Hedged Item
Description of hedged item	Forecast purchases of tobacco in Brazil
Derivatives Not Designated as Hedges - Forward Foreign Currency Exchange Contracts
Gain (loss) recognized in earnings	$	10,524		$	4,176		$	8,380		$	2,881
Location of gain (loss) recognized in earnings	Selling, general and administrative expenses

For the interest rate swap agreements, the effective portion of the gain or loss on the derivative is recorded in accumulated other comprehensive loss and any ineffective portion is recorded in selling, general and administrative expenses. For the forward foreign currency exchange contracts designated as cash flow hedges of tobacco purchases in Brazil, a net hedge gain of approximately $0.6 million remained in accumulated other comprehensive loss at September 30, 2015. That balance reflects gains and losses on contracts related to the 2015 crop, less the amount reclassified to earnings related to tobacco sold through September 30, 2015. The majority of the balance in accumulated other comprehensive loss is expected to be recognized in earnings as a component of cost of goods sold in fiscal year 2016 as the related tobaccos are sold to customers. Based on the hedging strategy, as the gain or loss is recognized in earnings, it is expected to be offset by a change in the direct cost for the tobacco or by a change in sales prices if the strategy has been mandated by the customer. Generally, margins on the sale of the tobacco will not be significantly affected.

13

Effect of Derivative Financial Instruments on the Consolidated Balance Sheets

The table below outlines the effects of the Company’s derivative financial instruments on the consolidated balance sheets at September 30, 2015 and 2014, and March 31, 2015:

	Derivatives in a Fair Value Asset Position							Derivatives in a Fair Value Liability Position
	Balance Sheet Location	Fair Value as of						Balance Sheet Location	Fair Value as of
(in thousands of dollars)		Sept. 30, 2015		Sept. 30, 2014		March 31, 2015			Sept. 30, 2015		Sept. 30, 2014		March 31, 2015
Derivatives Designated as Hedging Instruments
Interest rate swap agreements	Other non-current assets	$	—	$	—	$	—	Other long-term liabilities	$	6,430	$	638	$	3,050
Forward foreign currency exchange contracts	Other current assets	—		—		106		Accounts payable and accrued expenses	—		—		396
Total		$	—	$	—	$	106		$	6,430	$	638	$	3,446
Derivatives Not Designated as Hedging Instruments
Forward foreign currency exchange contracts	Other current assets	$	4,354	$	5,172	$	5,148	Accounts payable and accrued expenses	$	12	$	109	$	183
Total		$	4,354	$	5,172	$	5,148		$	12	$	109	$	183

Substantially all of the Company's forward foreign exchange contracts are subject to master netting arrangements whereby the right to offset occurs in the event of default by a participating party. The Company has elected to present these contracts on a gross basis in the consolidated balance sheets.

NOTE 8.   FAIR VALUE MEASUREMENTS

Universal measures certain financial and nonfinancial assets and liabilities at fair value based on applicable accounting guidance. The financial assets and liabilities measured at fair value include money market funds, trading securities associated with deferred compensation plans, interest rate swap agreements, forward foreign currency exchange contracts, and guarantees of bank loans to tobacco growers. The application of the fair value guidance to nonfinancial assets and liabilities primarily includes the determination of fair value for goodwill and long-lived assets when indicators of potential impairment are present.

Under the accounting guidance, fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. The framework for measuring fair value is based on a fair value hierarchy that distinguishes between observable inputs and unobservable inputs. Observable inputs are based on market data obtained from independent sources. Unobservable inputs require the Company to make its own assumptions about the value placed on an asset or liability by market participants because little or no market data exists. There are three levels within the fair value hierarchy:

Level	Description
1	quoted prices in active markets for identical assets or liabilities that the Company has the ability to access as of the reporting date;
2	quoted prices in active markets for similar assets or liabilities, or quoted prices for identical or similar assets or liabilities in markets that are not active, or inputs other than quoted prices that are observable for the asset or liability; and
3	unobservable inputs for the asset or liability.

In measuring the fair value of liabilities, the Company considers the risk of non-performance in determining fair value. Universal has not elected to report at fair value any financial instruments or any other assets or liabilities that are not required to be reported at fair value under current accounting guidance.

14

At September 30, 2015 and 2014, and at March 31, 2015, the Company had certain financial assets and financial liabilities that were required to be measured and reported at fair value on a recurring basis. These assets and liabilities are listed in the tables below and are classified based on how their values were determined under the fair value hierarchy:

	September 30, 2015
(in thousands of dollars)	Level 1		Level 2		Level 3		Total
Assets
Money market funds	$	—	$	1,574	$	—	$	1,574
Trading securities associated with deferred compensation plans	18,359		—		—		18,359
Forward foreign currency exchange contracts	—		4,354		—		4,354
Total financial assets measured and reported at fair value	$	18,359	$	5,928	$	—	$	24,287
Liabilities
Guarantees of bank loans to tobacco growers	$	—	$	—	$	1,356	$	1,356
Interest rate swap agreements	—		6,430		—		6,430
Forward foreign currency exchange contracts	—		13		—		13
Total financial liabilities measured and reported at fair value	$	—	$	6,443	$	1,356	$	7,799

	September 30, 2014
(in thousands of dollars)	Level 1		Level 2		Level 3		Total
Assets
Money market funds	$	—	$	1,527	$	—	$	1,527
Trading securities associated with deferred compensation plans	20,039		—		—		20,039
Forward foreign currency exchange contracts	—		5,172		—		5,172
Total financial assets measured and reported at fair value	$	20,039	$	6,699	$	—	$	26,738
Liabilities
Guarantees of bank loans to tobacco growers	$	—	$	—	$	1,797	$	1,797
Interest rate swap agreements	—		638		—		638
Forward foreign currency exchange contracts	—		109		—		109
Total financial liabilities measured and reported at fair value	$	—	$	747	$	1,797	$	2,544

15

	March 31, 2015
(in thousands of dollars)	Level 1		Level 2		Level 3		Total
Assets
Money market funds	$	—	$	86,552	$	—	$	86,552
Trading securities associated with deferred compensation plans	20,692		—		—		20,692
Forward foreign currency exchange contracts	—		5,254		—		5,254
Total financial assets measured and reported at fair value	$	20,692	$	91,806	$	—	$	112,498
Liabilities
Guarantees of bank loans to tobacco growers	$	—	$	—	$	1,674	$	1,674
Interest rate swap agreements	—		3,050		—		3,050
Forward foreign currency exchange contracts	—		579		—		579
Total financial liabilities measured and reported at fair value	$	—	$	3,629	$	1,674	$	5,303

Money market funds

The fair value of money market funds, which are reported in cash and cash equivalents in the consolidated balance sheets, is based on net asset value, which is computed based on amortized cost (Level 2). The fair values of these investments approximate cost due to the short-term maturities and the high credit quality of the issuers of the underlying securities.

Trading securities associated with deferred compensation plans

Trading securities represent mutual fund investments that are matched to employee deferred compensation obligations. These investments are bought and sold as employees defer compensation, receive distributions, or make changes in the funds underlying their accounts. Quoted market prices (Level 1) are used to determine the fair values of the mutual funds.

Interest rate swap agreements

The fair values of interest rate swap agreements are determined based on dealer quotes using a discounted cash flow model matched to the contractual terms of each instrument. Since inputs to the model are observable and significant judgment is not required in determining the fair values, interest rate swaps are classified within Level 2 of the fair value hierarchy.

Forward foreign currency exchange contracts

The fair values of forward foreign currency exchange contracts are also determined based on dealer quotes using a discounted cash flow model matched to the contractual terms of each instrument. Since inputs to the model are observable and significant judgment is not required in determining the fair values, forward foreign currency exchange contracts are classified within Level 2 of the fair value hierarchy.

Guarantees of bank loans to tobacco growers

The Company guarantees bank loans to tobacco growers in Brazil for crop financing and has previously guaranteed loans to those growers for the construction of curing barns or other tobacco producing assets. In the event that the farmers default on their payments to the banks, the Company would be required to perform under the guarantees. The Company regularly evaluates the likelihood of farmer defaults based on an expected loss analysis and records the fair value of its guarantees as an obligation in its consolidated financial statements. The fair value of the guarantees is determined using the expected loss data for all loans outstanding at each measurement date. The present value of the cash flows associated with the estimated losses is then calculated at a risk-adjusted interest rate that is aligned with the expected duration of the liability and includes an adjustment for nonperformance risk. This approach is sometimes referred to as the “contingent claims valuation method.” Although historical loss data is an observable input, significant judgment is required in applying this information to the portfolio of guaranteed loans outstanding at each measurement date and in selecting a risk-adjusted interest rate. Significant increases or decreases in the risk-adjusted interest rate may result in a significantly higher or lower fair value measurement. The guarantees of bank loans to tobacco growers are therefore classified within Level 3 of the fair value hierarchy.

16

A reconciliation of the change in the balance of the financial liability for guarantees of bank loans to tobacco growers (Level 3) for the six months ended September 30, 2015 and 2014 is provided below.

	Six Months Ended September 30,
(in thousands of dollars)	2015			2014
Balance at beginning of year	$	1,674		$	2,270
Payments under the guarantees and transfers to allowance for loss on direct loans to farmers (removal of prior crop year loans from portfolio)	(1,841		)	(2,392		)
Provision for loss or transfers from allowance for loss on direct loans to farmers (addition of current crop year loans)	1,821			2,022
Change in discount rate and estimated collection period	33			36
Currency remeasurement	(331		)	(139		)
Balance at end of period	$	1,356		$	1,797

Long-term Obligations

The fair value of the Company’s long-term obligations, including the current portion, was approximately $370 million at September 30, 2015, $350 million at September 30, 2014, and $370 million at March 31, 2015. The Company estimates the fair value of its long-term obligations using Level 2 inputs which are based upon quoted market prices for the same or similar issues or on the current interest rates available to the Company for debt of similar terms and maturities.

NOTE 9.   PENSION AND OTHER POSTRETIREMENT BENEFIT PLANS

The Company sponsors several defined benefit pension plans covering U.S. salaried employees and certain foreign and other employee groups. These plans provide retirement benefits based primarily on employee compensation and years of service. The Company also sponsors defined benefit plans that provide postretirement health and life insurance benefits for eligible U.S. employees attaining specific age and service levels.

The components of the Company’s net periodic benefit cost were as follows:

	Pension Benefits						Other Postretirement Benefits
	Three Months Ended September 30,						Three Months Ended September 30,
(in thousands of dollars)	2015			2014			2015			2014
Service cost	$	1,479		$	1,327		$	106		$	114
Interest cost	2,347			2,656			392			481
Expected return on plan assets	(3,577		)	(3,535		)	(15		)	(26		)
Curtailment gain	—			—			—			(1,503		)
Net amortization and deferral	1,199			780			(44		)	(133		)
Net periodic benefit cost	$	1,448		$	1,228		$	439		$	(1,067	)

17

	Pension Benefits						Other Postretirement Benefits
	Six Months Ended September 30,						Six Months Ended September 30,
(in thousands of dollars)	2015			2014			2015			2014
Service cost	$	2,962		$	2,661		$	214		$	228
Interest cost	4,693			5,325			799			965
Expected return on plan assets	(7,153		)	(7,227		)	(30		)	(52		)
Curtailment gain	—			—			—			(1,503		)
Net amortization and deferral	2,398			1,560			(88		)	(266		)
Net periodic benefit cost	$	2,900		$	2,319		$	895		$	(628	)

The net periodic benefit cost for the Company's pension and other postretirement benefit plans has increased from the prior fiscal year, primarily reflecting actuarial losses from lower market discount rates applicable to the most recent actuarial measurement of benefit liabilities and from lower expected long-term asset returns due to changes made during fiscal year 2015 to move toward a liability-driven investment strategy for the assets in the Company's U.S. ERISA-regulated defined benefit pension plan. The curtailment gain reflected in the above table for the three and six months ended September 30, 2014 was attributable to the elimination of postretirement life insurance benefits for active U.S. employees.

During the six months ended September 30, 2015, the Company made contributions of approximately $3.8 million to its pension plans. Additional contributions of approximately $8.6 million are expected during the remaining six months of fiscal year 2016, including $2.7 million to the Company's ERISA-regulated U.S. plan and $5.9 million to its non-ERISA regulated and other plans.

NOTE 10.   STOCK-BASED COMPENSATION

Universal’s shareholders have approved Executive Stock Plans (“Plans”) under which officers, directors, and employees of the Company may receive grants and awards of common stock, restricted stock, restricted stock units (“RSUs”), performance share awards (“PSAs”), stock appreciation rights (“SARs”), incentive stock options, and non-qualified stock options. The Company’s practice is to award grants of stock-based compensation to officers on an annual basis at the first regularly-scheduled meeting of the Executive Compensation, Nominating and Corporate Governance Committee of the Board of Directors (the “Compensation Committee”) in the fiscal year following the public release of the Company’s financial results for the prior year. The Compensation Committee administers the Company’s Plans consistently, following previously defined guidelines. Awards of restricted stock, RSUs, PSAs, and SARs are currently outstanding under the Plans. The SARs have an exercise price equal to the closing price of a share of the Company's common stock on the grant date. They are settled in shares of common stock, vest in equal one-third tranches one, two, and three years after the grant date, and expire ten years after the grant date, except that SARs granted after fiscal year 2007 expire on the earlier of three years after the grantee’s retirement date or ten years after the grant date. The RSUs vest five years from the grant date and are then paid out in shares of common stock. Under the terms of the RSU awards, grantees receive dividend equivalents in the form of additional RSUs that vest and are paid out on the same date as the original RSU grant. The PSAs vest three years from the grant date, are paid out in shares of common stock at the vesting date, and do not carry rights to dividends or dividend equivalents prior to vesting. Shares ultimately paid out under PSA grants are dependent on the achievement of predetermined performance measures established by the Compensation Committee and can range from zero to 150% of the stated award. The Company’s outside directors automatically receive restricted stock units or shares of restricted stock following each annual meeting of shareholders. RSUs awarded to outside directors vest three years after the grant date, and restricted shares vest upon the individual’s retirement from service as a director.

18

During the six-month periods ended September 30, 2015 and 2014, Universal issued the following stock-based awards, representing the regular annual grants to officers and outside directors of the Company:

	Six Months Ended September 30,
	2015		2014
RSUs:
Number granted	67,750		79,950
Grant date fair value	$	52.10	$	52.78
PSAs:
Number granted	57,750		48,450
Grant date fair value	$	45.06	$	46.41

As indicated in the table above, the Compensation Committee awarded only grants of RSUs and PSAs in both the current and prior fiscal years, and did not award any other types of stock-based compensation.

Fair value expense for stock-based compensation is recognized ratably over the period from grant date to the earlier of: (1) the vesting date of the award, or (2) the date the grantee is eligible to retire without forfeiting the award. For employees who are already eligible to retire at the date an award is granted, the total fair value of all non-forfeitable awards is recognized as expense at the date of grant. As a result, Universal typically incurs higher stock compensation expense in the first quarter of each fiscal year when grants are awarded to officers than in the other three quarters. For PSAs, the Company generally recognizes fair value expense ratably over the performance and vesting period based on management’s judgment of the ultimate award that is likely to be paid out based on the achievement of the predetermined performance measures. For the six-month periods ended September 30, 2015 and 2014, the Company recorded total stock-based compensation expense of approximately $3.0 million and $3.8 million, respectively. The Company expects to recognize stock-based compensation expense of approximately $2.3 million during the remaining six months of fiscal year 2016.

19

NOTE 11. OPERATING SEGMENTS

The principal approach used by management to evaluate the Company’s performance is by geographic region, although the dark air-cured and oriental tobacco businesses are each evaluated on the basis of their worldwide operations. The Company evaluates the performance of its segments based on operating income after allocated overhead expenses (excluding significant non-recurring charges or credits), plus equity in the pretax earnings of unconsolidated affiliates.

Operating results for the Company’s reportable segments for each period presented in the consolidated statements of income were as follows:

	Three Months Ended September 30,						Six Months Ended September 30,
(in thousands of dollars)	2015			2014			2015			2014
SALES AND OTHER OPERATING REVENUES
Flue-Cured and Burley Leaf Tobacco Operations:
North America	$	49,421		$	53,308		$	97,993		$	85,006
Other Regions (1)	371,032			371,669			548,433			569,241
Subtotal	420,453			424,977			646,426			654,247
Other Tobacco Operations (2)	35,929			39,139			85,375			81,341
Consolidated sales and other operating revenues	$	456,382		$	464,116		$	731,801		$	735,588
OPERATING INCOME
Flue-Cured and Burley Leaf Tobacco Operations:
North America	$	3,783		$	4,278		$	7,199		$	5,957
Other Regions (1)	34,202			21,661			26,355			11,086
Subtotal	37,985			25,939			33,554			17,043
Other Tobacco Operations (2)	145			2,640			1,053			3,900
Segment operating income	38,130			28,579			34,607			20,943
Deduct: Equity in pretax earnings of unconsolidated affiliates (3)	(846		)	(3,317		)	(230		)	(3,918		)
Restructuring and impairment costs (4)	—			(3,350		)	(2,389		)	(3,350		)
Consolidated operating income	$	37,284		$	21,912		$	31,988		$	13,675

⁽¹⁾  Includes South America, Africa, Europe, and Asia regions, as well as inter-region eliminations.

⁽²⁾  Includes Dark Air-Cured, Special Services, and Oriental, as well as inter-company eliminations. Sales and other operating revenues for this reportable segment include limited amounts for Oriental because its financial results consist principally of equity in the pretax earnings of an unconsolidated affiliate.

⁽³⁾  Equity in pretax earnings of unconsolidated affiliates is included in segment operating income (Other Tobacco Operations segment), but is reported below consolidated operating income and excluded from that total in the consolidated statements of income and comprehensive income.

⁽⁴⁾  Restructuring and impairment costs are excluded from segment operating income, but are included in consolidated operating income in the consolidated statements of income and comprehensive income.

20

NOTE 12. ACCUMULATED OTHER COMPREHENSIVE INCOME (LOSS)

The following table summarizes the changes in the accumulated balances for each component of accumulated other comprehensive income (loss) attributable to the Company for the six months ended September 30, 2015 and 2014:

	Six Months Ended September 30,
(in thousands of dollars)	2015			2014
Foreign currency translation:
Balance at beginning of year	$	(31,138	)	$	(8,476	)
Other comprehensive income (loss) attributable to Universal Corporation:
Net gain (loss) on foreign currency translation (net of tax (expense) benefit of $(1,155) and $4,921)	2,147			(9,138		)
Less: Net gain (loss) on foreign currency translation attributable to noncontrolling interests	426			(37		)
Other comprehensive income (loss) attributable to Universal Corporation, net of income taxes	2,573			(9,175		)
Balance at end of period	$	(28,565	)	$	(17,651	)
Foreign currency hedge:
Balance at beginning of year	$	(1,834	)	$	769
Other comprehensive income (loss) attributable to Universal Corporation:
Net gain (loss) on derivative instruments (net of tax (expense) benefit of $(878) and $571)	1,629			(1,060		)
Reclassification of gain to earnings (net of tax expense of $90 and $385)(1)	(166		)	(715		)
Other comprehensive income (loss) attributable to Universal Corporation, net of income taxes	1,463			(1,775		)
Balance at end of period	$	(371	)	$	(1,006	)
Interest rate hedge:
Balance at beginning of year	$	(1,982	)	$	(608	)
Other comprehensive income (loss) attributable to Universal Corporation:
Net loss on derivative instruments (net of tax benefit of $2,120 and $38)	(3,937		)	(69		)
Reclassification of loss to earnings (net of tax benefit of $(936) and $(142))(2)	1,740			263
Other comprehensive income (loss) attributable to Universal Corporation, net of income taxes	(2,197		)	194
Balance at end of period	$	(4,179	)	$	(414	)
Pension and other postretirement benefit plan:
Balance at beginning of year	$	(40,040	)	$	(26,017	)
Other comprehensive income (loss) attributable to Universal Corporation:
Amortization included in earnings (net of tax benefit of $(844) and $(550)) (3)	1,498			1,087
Other comprehensive income (loss) attributable to Universal Corporation, net of income taxes	1,498			1,087
Balance at end of period	$	(38,542	)	$	(24,930	)
Total accumulated other comprehensive income (loss) at end of period	$	(71,657	)	$	(44,001	)

⁽¹⁾ Gain (loss) on foreign currency cash flow hedges related to forecast purchases of tobacco is reclassified from accumulated other comprehensive income (loss) to cost of goods sold when the tobacco is sold to customers. See Note 7 for additional information.

⁽²⁾ Gain (loss) on interest rate cash flow hedges is reclassified from accumulated other comprehensive income (loss) to interest expense when the related interest payments are made on the debt or upon termination of the interest rate swap agreements prior to their scheduled maturity dates. See Note 7 for additional information.

⁽³⁾ This accumulated other comprehensive income (loss) component is included in the computation of net periodic benefit cost. See Note 9 for additional information.

21

NOTE 13. CHANGES IN SHAREHOLDERS' EQUITY AND NONCONTROLLING INTERESTS IN SUBSIDIARIES

A reconciliation of the changes in Universal Corporation shareholders’ equity and noncontrolling interests in subsidiaries for the six months ended September 30, 2015 and 2014 is as follows:

	Six Months Ended September 30, 2015									Six Months Ended September 30, 2014
(in thousands of dollars)	Universal Corporation			Non-controlling Interests			Total			Universal Corporation			Non-controlling Interests			Total
Balance at beginning of year	$	1,362,725		$	34,369		$	1,397,094		$	1,378,230		$	32,662		$	1,410,892
Changes in common stock
Issuance of common stock	—			—			—			187			—			187
Repurchase of common stock	—			—			—			(1,143		)	—			(1,143		)
Accrual of stock-based compensation	3,020			—			3,020			3,755			—			3,755
Withholding of shares from stock-based compensation for grantee income taxes	(2,037		)	—			(2,037		)	(2,009		)	—			(2,009		)
Dividend equivalents on RSUs	364			—			364			316			—			316
Changes in retained earnings
Net income	16,518			2,421			18,939			15,742			267			16,009
Cash dividends declared
Series B 6.75% convertible perpetual preferred stock	(7,374		)	—			(7,374		)	(7,425		)	—			(7,425		)
Common stock	(23,582		)	—			(23,582		)	(23,644		)	—			(23,644		)
Repurchase of common stock	—			—			—			(6,059		)	—			(6,059		)
Dividend equivalents on RSUs	(364		)	—			(364		)	(316		)	—			(316		)
Other comprehensive income (loss)	3,337			(426		)	2,911			(9,669		)	(37		)	(9,706		)
Dividends paid to noncontrolling shareholders	—			(1,260		)	(1,260		)	—			(1,977		)	(1,977		)
Balance at end of period	$	1,352,607		$	35,104		$	1,387,711		$	1,347,965		$	30,915		$	1,378,880

22

ITEM 2. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

This Quarterly Report on Form 10-Q and the following “Management’s Discussion and Analysis of Financial Condition and Results of Operations” contain “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Among other things, these statements relate to the Company’s financial condition, results of operation, and future business plans, operations, opportunities, and prospects. In addition, the Company and its representatives may from time to time make written or oral forward-looking statements, including statements contained in other filings with the Securities and Exchange Commission and in reports to shareholders. These forward-looking statements are generally identified by the use of words such as we “expect,” “believe,” “anticipate,” “could,” “should,” “may,” “plan,” “will,” “predict,” “estimate,” and similar expressions or words of similar import. These forward-looking statements are based upon management’s current knowledge and assumptions about future events and involve risks and uncertainties that could cause actual results, performance, or achievements to be materially different from any anticipated results, prospects, performance, or achievements expressed or implied by such forward-looking statements. Such risks and uncertainties include, but are not limited to, anticipated levels of demand for and supply of our products and services; costs incurred in providing these products and services; timing of shipments to customers; changes in market structure; government regulation; product taxation; industry consolidation and evolution; changes in exchange rates and interest rates; regulation and litigation impacts on our customers; and general economic, political, market, and weather conditions. For a further description of factors that may cause actual results to differ materially from such forward-looking statements, see Item 1A, “Risk Factors” of our Annual Report on Form 10-K for the fiscal year ended March 31, 2015. We caution investors not to place undue reliance on any forward-looking statements as these statements speak only as of the date when made, and we undertake no obligation to update any forward-looking statements made in this report. This Form 10-Q should be read in conjunction with our Annual Report on Form 10-K for the fiscal year ended March 31, 2015.

Liquidity and Capital Resources

Overview

The first six months of the fiscal year is generally a period of significant working capital investment in both Africa and South America as crops are delivered by farmers. We funded our working capital needs in the quarter ended September 30, 2015, using a combination of cash on hand, short-term borrowings, customer advances, and operating cash flows. Similar to the prior fiscal year, we expect shipments to be heavily weighted to the second half of the fiscal year which may extend the duration of our working capital needs in some origins.

Our liquidity and capital resource requirements are predominantly short term in nature and relate to working capital for tobacco crop purchases. Working capital needs are seasonal within each geographic region. The geographic dispersion and the timing of working capital needs permit us to predict our general level of cash requirements, although crop size, prices paid to farmers, shipment and delivery timing, and currency fluctuations affect requirements each year. Peak working capital requirements are generally reached during the first and second fiscal quarters. Each geographic area follows a cycle of buying, processing, and shipping, and in many regions, we also provide agricultural materials to farmers during the growing season. The timing of the elements of each cycle is influenced by such factors as local weather conditions and individual customer shipping requirements, which may change the level or the duration of crop financing. Despite a predominance of short-term needs, we maintain a portion of our total debt as long-term to reduce liquidity risk. We also periodically have large cash balances that we utilize to meet our working capital requirements.

Operating Activities

We used $143.8 million in net cash flows to fund our operating activities during the six months ended September 30, 2015. That amount was $209.9 million lower than the level we required during the same period last fiscal year mainly due to lower overall green leaf prices and purchase volumes and shipment timing. Tobacco inventory increased by $362.8 million from March 31, 2015 levels on seasonal leaf purchases to $999.3 million at September 30, 2015. Tobacco inventory levels were $165.0 million below September 30, 2014 levels, largely due to lower overall green leaf prices, particularly in Brazil due to currency devaluation, earlier shipments from some origins in Africa and Asia, and shipments of carryover crops in the first half of this fiscal year. Inventory is usually financed with a mix of cash, notes payable, and customer deposits, depending on our available cash balances, borrowing capabilities, interest rates, and exchange rates, as well as those of our customers. We generally do not purchase material quantities of tobacco on a speculative basis. However, when we contract directly with farmers, we are often obligated to buy all stalk positions, which may contain less marketable leaf styles. At September 30, 2015, our uncommitted inventories were $146.7 million, or about 15% of total tobacco inventory, compared to $151.1 million, or about 24% of our March 31, 2015 inventory, and $171.5 million, or about 15% of our September 30, 2014 inventory. The level of these uncommitted inventories percentages is influenced by timing of farmer deliveries of new crops, as well as the timing of customer orders.

23

Our balance sheet accounts reflected seasonal patterns in the quarter ended September 30, 2015, on deliveries of crops by farmers in both South America and Africa. Cash and cash equivalent balances decreased by $179.8 million from March 31, 2015 levels as we used cash to fund seasonal working capital needs. Accounts receivable decreased by $130.4 million compared to March 31, 2015, reflecting collections of receivables. Advances to suppliers were $40.6 million at September 30, 2015, a reduction of $74.3 million from March 31, 2015, as crops were delivered in payment of those balances. Conversely, accounts receivable from unconsolidated affiliates were up $57.5 million from March 31, 2015 levels, reflecting seasonal increases. Customer advances and deposits were up $36.9 million over March 31, 2015 levels, reflecting deposits against upcoming crop shipments.

Compared to September 30, 2014 levels, advances to suppliers were down $29.7 million on weaker local currency rates in some origins and timing of collections on advances. Accounts receivable - unconsolidated affiliates were $59.4 million at September 30, 2015, a decrease of $39.3 million on reduced crop purchases in certain origins.

Investing Activities

Our capital expenditures are generally limited to those that add value, replace or maintain equipment, increase efficiency, or position us for future growth. In deciding where to invest capital resources, we look for opportunities where we believe we can earn an adequate return, leverage our assets and expertise, and enhance our farmer base. During the six months ended September 30, 2015 and 2014, we invested about $28.5 million and $30.6 million, respectively, in our fixed assets. Depreciation expense was approximately $18.4 million and $17.3 million for the six months ended September 30, 2015 and 2014, respectively. Generally, our routine capital spending is at a level below depreciation expense in order to maintain strong cash flow. However, from time to time, we undertake projects that increase capital spending beyond those limits when we identify opportunities to improve efficiencies, add value for our customers, and position us for future growth. We currently plan to spend approximately $45 to $50 million over the next twelve months on capital projects for maintenance of our facilities, completion of the new manufacturing facility for our food ingredients business, and other investments to grow and improve our tobacco business.

Financing Activities

We consider the sum of notes payable and overdrafts, long-term debt (including the current portion), and customer advances and deposits, less cash, cash equivalents, and short-term investments on our balance sheet to be our net debt. We also consider our net debt plus shareholders' equity to be our net capitalization. Net debt increased by about $243.0 million to $454.2 million during the six months ended September 30, 2015, primarily due to seasonal working capital requirements. Net debt as a percentage of net capitalization of approximately 25% at September 30, 2015, was down from the September 30, 2014 level of approximately 35% and was up from about 13% at March 31, 2015, reflecting normal seasonal expansion. We entered fiscal year 2016 with cash and cash equivalent balances that were $85.3 million higher than the prior fiscal year which reduced our short-term borrowing requirements in the first six months of the fiscal year. Our borrowing needs were further reduced by lower green tobacco costs this fiscal year. As of September 30, 2015, we had $69.0 million in cash and cash equivalents, our short-term debt totaled $86.1 million, and we were in compliance with all covenants of our debt agreements, which require us to maintain certain levels of tangible net worth and observe restrictions on debt levels.

As of September 30, 2015, we had $410.0 million available under a committed revolving credit facility that will mature in December 2019, and we had about $292.4 million in unused, uncommitted credit lines. We also maintain an effective, undenominated universal shelf registration that provides for future issuance of additional debt or equity securities. We have no long-term debt maturing in fiscal year 2016. Our seasonal working capital requirements typically increase significantly between March and September and decline after mid-year. Available capital resources from our cash balances, committed credit facility, and uncommitted credit lines exceed our normal working capital needs and currently anticipated capital expenditure requirements over the next twelve months.

In November 2013, our Board of Directors approved a $100 million share repurchase program that was replaced in November 2015. The purchases under this program were carried out from time to time on the open market at prices not exceeding prevailing market rates. During the six months ended September 30, 2015, we did not purchase any shares of our common or preferred stock. On November 5, 2015, we announced that our Board of Directors had approved a new authorization for the purchase of up to $100 million in equity securities through November 15, 2017. The purchases may be carried out from time to time on the open market or in privately negotiated transactions at prices not exceeding prevailing market rates. In determining our level of common and preferred share repurchase activity, our intent is to use only cash available after meeting our anticipated capital investment, dividend, and working capital requirements. Repurchases of shares under the repurchase program may vary based on management discretion, as well as changes in cash flow generation and availability. As of September 30, 2015, approximately 22.7 million shares of our common stock and 218,490 shares of our preferred stock were outstanding.

24

Derivatives

From time to time, we use interest rate swap agreements to manage our exposure to changes in interest rates. At September 30, 2015, the fair value of our outstanding interest rate swap agreements was a liability of about $6.4 million, and the notional amount swapped was approximately $370 million. We entered into these agreements to eliminate the variability of cash flows in the interest payments on our variable-rate term loans. Under the swap agreements we receive variable rate interest and pay fixed rate interest. The swaps are accounted for as cash flow hedges.

We also enter forward contracts from time to time to hedge certain foreign currency exposures, primarily related to forecast purchases of tobacco and related processing costs in Brazil, as well as our net monetary asset exposure in local currency there. We generally account for our hedges of forecast tobacco purchases as cash flow hedges. At September 30, 2015, we had no open hedge contracts for those purposes. We had forward contracts outstanding that were not designated as hedges, and the fair value of those contracts was a net asset of about $4.3 million at September 30, 2015.

Results of Operations

Amounts described as net income and earnings per diluted share in the following discussion are attributable to Universal Corporation and exclude earnings related to non-controlling interests in subsidiaries. The total for segment operating income (loss) referred to in the discussion below is a non-GAAP financial measure. This measure is not a financial measure calculated in accordance with GAAP and should not be considered as a substitute for net income, operating income (loss), cash from operating activities or any other operating performance measure calculated in accordance with GAAP, and it may not be comparable to similarly titled measures reported by other companies. We have provided a reconciliation of the total for segment operating income (loss) to consolidated operating income (loss) in Note 11. "Operating Segments" to the consolidated financial statements in Item 1. We evaluate our segment performance excluding certain significant charges or credits. We believe this measure, which excludes these items that we believe are not indicative of our core operating results, provides investors with important information that is useful in understanding our business results and trends.

Net income for the first half of fiscal year 2016, which ended on September 30, 2015, was $16.5 million, or $0.40 per diluted share, compared with $15.7 million, or $0.35 per diluted share for the same period last year. Results for the six months ended September 30, 2015, included restructuring and impairment costs of $2.4 million ($0.07 per diluted share). Last year’s results for the six months ended September 30, 2014, included an income tax benefit of $8.0 million (or $0.34 per diluted share), arising from a subsidiary’s payment of a portion of a fine following the unsuccessful appeal of a long-running court case, and restructuring costs of $3.4 million ($0.09 per diluted share). Excluding those items in both years, net income for the six months increased $8.1 million ($0.37 per diluted share) compared to the same period last year. For the second fiscal quarter ended September 30, 2015, net income was $22.5 million, or $0.81 per diluted share, compared with net income for the prior year’s second quarter of $15.0 million, or $0.48 per diluted share.

Segment operating income for the first half of fiscal year 2016 was $34.6 million, an increase of $13.7 million, and for the quarter ended September 30, 2015, was $38.1 million, an increase of $9.6 million, both compared to the same periods last fiscal year. Those increases resulted primarily from earnings improvements in the Other Regions segment, offset in part by declines in the Other Tobacco Operations segment. Consolidated revenues decreased by 1% to $731.8 million for the first half of fiscal year 2016, and by 2% to $456.4 million for the three months ended September 30, 2015, compared to the same periods in the prior year, mostly as a result of higher volumes offset by lower average green prices, as well as lower processing revenues.

Flue-cured and Burley Leaf Tobacco Operations

Other Regions

Operating income for the Other Regions segment increased by $15.3 million to $26.4 million for the first half of fiscal year 2016, compared to the first half of the prior fiscal year. The improvement was largely attributable to reduced selling, general, and administrative costs, although higher sales volumes for the segment and better overall margins in most regions also contributed to the earnings increase. Sales from carryover crops in Africa and higher volumes in Asia helped mitigate declining volumes and the effect of devaluation of local currencies on U.S. dollar-translated results for the Europe region. The South America region saw positive cost comparisons in the first half of the year from the suspension of operations in Argentina last year. Selling, general, and administrative expenses for the segment improved on the absence of last year’s large value-added tax valuation provision, lower incentive compensation costs, and the impact of a stronger U.S. dollar on local currency expenses. These improvements were partially offset by higher net currency remeasurement and exchange losses, mainly in Africa and Asia, and the costs incurred in the current quarter to settle third party challenges to the property rights and valuation of a large tract of forestry land. Revenues for the Other

25

Regions segment for the six months ended September 30, 2015 were down about 4% to $548.4 million, reflecting the higher volumes at lower average green leaf prices for the segment as a whole, as well as a decline in processing revenues.

Operating income for the Other Regions segment increased $12.6 million to $34.2 million in the quarter ended September 30, 2015, compared with the quarter ended September 30, 2014. A combination of stronger sales volumes, lower inventory writedowns, lower green leaf costs, a better product mix, and lower local-currency factory overheads contributed to improved margins for the segment. Selling, general, and administrative expenses declined slightly for this segment in the second fiscal quarter as lower incentive compensation costs and the positive effect of the stronger U.S. dollar on other local currency-denominated overheads were partly offset by the costs to settle third party challenges to the property rights and valuation of a large tract of forestry land. Revenues for the Other Regions segment declined slightly by $0.6 million to $371.0 million in the quarter ended September 30, 2015, compared with the prior year, on higher total volumes and a better mix, offset by lower average green prices and processing revenues.

North America

North America segment operating income of $7.2 million for the six months ended September 30, 2015, increased by $1.2 million, compared with the same period in the previous year. The improvement was driven by higher domestic volumes, mainly from carryover crop sales in the first fiscal quarter. Selling, general and administrative costs were higher for the period, but were flat as a percentage of sales. Segment revenues for the first half of fiscal year 2016 increased by $13.0 million to $98.0 million on those higher volumes, offset by modest declines in processing revenues and a less favorable product mix.

Segment operating income for the second quarter of fiscal year 2016 of $3.8 million was down by $0.5 million from last year’s comparable quarter. The earnings decline was mainly driven by higher selling, general, and administrative costs, including variances related to provisions for supplier advances and currency remeasurement losses in Mexico. Second quarter fiscal year 2016 revenues declined by about 7% to $49.4 million for the segment, mainly from lower sales and processing volumes.

Other Tobacco Operations

For the first half of fiscal year 2016, the Other Tobacco Operations segment’s operating income decreased by $2.8 million to $1.1 million from results for the same period last fiscal year. Earnings improved for the dark tobacco operations on higher volumes, as well as better margins and lower compensation costs. That improvement was offset by reduced earnings for the oriental joint venture due to lower volumes, partly resulting from later shipments this fiscal year, and higher currency remeasurement losses. In addition, the special services group incurred losses primarily on continuing startup costs for the new food ingredients business. Selling, general, and administrative costs for the segment were flat for the first half of the current fiscal year compared with the previous year. Revenues for the Other Tobacco Operations segment increased by $4.0 million to $85.4 million for the first half of fiscal year 2016, as the stronger volumes for the dark tobacco operations were partly offset by volume declines due to the timing of shipments of oriental tobaccos into the United States.

The Other Tobacco Operations segment operating income declined by $2.5 million to $0.1 million for the quarter ended September 30, 2015, compared with the same period for the previous fiscal year. Results for the dark tobacco business improved slightly for the second fiscal quarter, on better margins and stronger service cutting volumes. Selling, general, and administrative costs in the second fiscal quarter for the segment were negatively impacted by higher costs for the special services group and from higher currency remeasurement and exchange losses, mainly in the dark tobacco operations. Results in the fiscal quarter were down for the oriental joint venture on reduced volumes, due in part to shipments delayed into the second half of the fiscal year, and higher currency remeasurement losses, despite lower administrative costs for the period. Revenues for the segment declined by $3.2 million to $35.9 million for the second fiscal quarter as the improvements for the dark tobacco business were outweighed by lower sales volumes due to the timing of shipments of oriental tobaccos into the United States, compared to the same period in the prior year.

Other Information

Cost of goods sold decreased by about 2% to $585.3 million for the first half, and by about 5% to $358.3 million for the second quarter of fiscal year 2016. For both periods, the reductions reflect the lower revenues in the respective periods, from lower overall leaf prices, and improved margins. The second fiscal quarter was also influenced by an improved product mix and lower inventory writedowns.

Selling, general, and administrative costs decreased by $11.5 million in the first half of fiscal year 2016 and increased by $1.0 million for the second fiscal quarter compared with the same periods in the prior fiscal year. In both periods, benefits were achieved from a combination of items, including favorable comparisons to last year’s accruals for value-added tax reserves, lower loss provisions on advances to suppliers, lower incentive compensation costs, and reductions in local currency-denominated expenses

26

from devaluation of foreign currencies, mainly in South America and Africa. Expense increases in the periods were driven by larger currency remeasurement losses, mainly in Africa and Asia, and the costs incurred in the current quarter to settle third party challenges to the property rights and valuation of a large tract of forestry land.

The consolidated effective income tax rates were approximately 27% and 24% for the quarters ended September 30, 2015 and 2014, respectively. The consolidated effective tax rate for the six-month period ended September 30, 2015, was approximately 24%. Income taxes for the first half of fiscal year 2015 were impacted by a non-recurring benefit of $8.0 million arising from the partial payment of the European Commission fine by our Italian subsidiary in June 2014.  Excluding that item, the consolidated effective tax rate for the six months ended September 30, 2014, was approximately 10%. The rates for all periods were lower than the 35% federal statutory rate because of lower net effective tax rates on income from certain foreign subsidiaries, as well as effects of changes in local currency exchange rates on deferred income tax balances.

General Overview

We are pleased with the performance of our operations in the first half of this year, which has progressed as expected given the lingering effects of an oversupplied market. Our results for the six months ended September 30, 2015, include higher sales volumes, lower overhead costs, and better overall margins in our key operating regions, due in part to efforts in recent years to improve efficiencies and reduce costs in our business. We continue to support supply chain efficiencies such as in Poland where we recently announced an agreement to assume processing of tobaccos in crop year 2015 for a major customer, giving rise to improved processing efficiencies in that country.    

We still anticipate that total lamina sales volumes from the current year’s crops will slightly exceed those of last year. Similar to last year, we expect strong shipments in the second half of the fiscal year, but this year we expect much heavier volumes will ship in the fourth fiscal quarter. Due to this later timing, and depending upon factors such as port and container availability, some shipments may fall into the first fiscal quarter of 2017.

We are monitoring weather conditions around the world that will likely have a negative impact on 2016 crop quality and production levels. As a result of the recent heavy rains and hail in southern Brazil from an El Nino weather pattern, we have reduced production projections for both flue-cured and burley in that country by about 8%. The smaller crop sizes could decrease our buying program there next year. The same weather pattern may also affect Africa, decreasing rainfall and impacting crop sizes and quality. We believe that the combination of this weather pattern and reduced plantings in some origins will bring markets largely into balance in fiscal year 2017.

Construction of the processing facility for our new food ingredients business has been substantially completed, and we expect to begin commercial production in our third fiscal quarter. In addition, as we begin the second half of our fiscal year, we believe we are well-positioned with low uncommitted inventories and a strong balance sheet, and we continue to reward our shareholders as evidenced by our 45^th consecutive annual dividend increase announced earlier today.

27

ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

Currency

The international leaf tobacco trade generally is conducted in U.S. dollars, thereby limiting foreign exchange risk to that which is related to leaf purchase and production costs, overhead, and income taxes in the source country. We also provide farmer advances that are directly related to leaf purchases and are denominated in the local currency. Any currency gains or losses on those advances are usually offset by decreases or increases in the cost of tobacco, which is priced in the local currency. However, the effect of the offset may not occur until a subsequent quarter or fiscal year. Most of our tobacco operations are accounted for using the U.S. dollar as the functional currency. Because there are no forward foreign exchange markets in many of our major countries of tobacco origin, we often manage our foreign exchange risk by matching funding for inventory purchases with the currency of sale, which is usually the U.S. dollar, and by minimizing our net local currency monetary position in individual countries. We are vulnerable to currency remeasurement gains and losses to the extent that monetary assets and liabilities denominated in local currency do not offset each other. In addition to foreign exchange gains and losses, we are exposed to changes in the cost of tobacco due to changes in the value of the local currency in relation to the U.S. dollar. We routinely enter forward currency exchange contracts to hedge against the effects of currency movements on purchases of tobacco to reduce the volatility of costs. In addition, from time-to-time we enter forward contracts to hedge balance sheet exposures.

In certain tobacco markets that are primarily domestic, we use the local currency as the functional currency. Examples of these markets are Hungary, Poland, and the Philippines. In other markets, such as Western Europe, where export sales have been primarily in local currencies, we also use the local currency as the functional currency. In each case, reported earnings are affected by the translation of the local currency into the U.S. dollar.

Interest Rates

We generally use both fixed and floating interest rate debt to finance our operations. Changes in market interest rates expose us to changes in cash flows for floating rate instruments and to changes in fair value for fixed-rate instruments. We normally maintain a proportion of our debt in both variable and fixed interest rates to manage this exposure, and from time to time we may enter hedge agreements to swap the interest rates. In addition, our customers may pay market rates of interest for inventory purchased on order, which could mitigate a portion of the floating interest rate exposure. We also periodically have large cash balances and may receive deposits from customers, both of which we use to fund seasonal purchases of tobacco, reducing our financing needs. Excluding our bank term loans which were converted to fixed-rate borrowings with interest rate swaps in January 2015, debt carried at variable interest rates was approximately $86 million at September 30, 2015. Although a hypothetical 1% change in short-term interest rates would result in a change in annual interest expense of approximately $1 million, that amount would be at least partially mitigated by changes in charges to customers.

Derivatives Policies

Hedging interest rate exposure using swaps and hedging foreign exchange exposure using forward contracts are specifically contemplated to manage risk in keeping with management's policies. We may use derivative instruments, such as swaps, forwards, or futures, which are based directly or indirectly upon interest rates and currencies to manage and reduce the risks inherent in interest rate and currency fluctuations. When we use foreign currency derivatives to mitigate our exposure to exchange rate fluctuations, we may choose not to designate them as hedges for accounting purposes, which may result in the effects of the derivatives being recognized in our earnings in periods different from the items that created the exposure.

We do not utilize derivatives for speculative purposes, and we do not enter into market risk-sensitive instruments for trading purposes. Derivatives are transaction specific so that a specific debt instrument, forecast purchase, contract, or invoice determines the amount, maturity, and other specifics of the hedge. We routinely review counterparty risk as part of our derivative program.

28

ITEM 4. CONTROLS AND PROCEDURES

We maintain disclosure controls and procedures that are designed to ensure that information required to be disclosed in reports we file under the Securities Exchange Act of 1934 (the “Exchange Act”), as amended, is recorded, processed, summarized and reported within the time periods specified in the Securities and Exchange Commission’s rules and forms and that such information is accumulated and communicated to management, including our Chief Executive Officer and Chief Financial Officer, as appropriate, to allow for timely decisions regarding required disclosure. Our Chief Executive Officer and Chief Financial Officer evaluated, with the participation of other members of management, the effectiveness of our disclosure controls and procedures (as defined in Exchange Act Rule 13a-15(e)), as of the end of the period covered by this Quarterly Report on Form 10-Q. Based on this evaluation, management concluded that our disclosure controls and procedures were effective. There were no changes in our internal controls over financial reporting identified in connection with this evaluation that occurred during our last fiscal quarter that have materially affected, or are reasonably likely to materially affect, our internal controls over financial reporting.

29

PART II. OTHER INFORMATION

ITEM 1.   LEGAL PROCEEDINGS

Some of our subsidiaries are involved in litigation or legal matters incidental to their business activities.  While the outcome of these matters cannot be predicted with certainty, we are vigorously defending them and do not currently expect that any of them will have a material adverse effect on our business or financial position. However, should one or more of these matters be resolved in a manner adverse to our current expectation, the effect on our results of operations for a particular fiscal reporting period could be material.

ITEM 1A. RISK FACTORS

As of the date of this report, there are no material changes to the risk factors previously disclosed in our Annual Report on Form 10-K for the year ended March 31, 2015. In evaluating our risks, readers should carefully consider the risk factors discussed in our Annual Report on Form 10-K, which could materially affect our business, financial condition or operating results, in addition to the other information set forth in this report and in our other filings with the Securities and Exchange Commission.

ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS

As indicated in the following table, we did not repurchase shares of our common stock or our Series B 6.75% convertible perpetual preferred stock during the three-month period ended September 30, 2015:

	Common Stock				Series B 6.75% Convertible Perpetual Preferred Stock
Period (1)	Total Number of Shares Repurchased	Average Price Paid Per Share (2)		Total Number of Shares Repurchased as Part of Publicly Announced Plans or Programs (3)	Total Number of Shares Repurchased	Average Price Paid Per Share (2)		Total Number of Shares Repurchased as Part of Publicly Announced Plans or Programs (3)	Dollar Value of Shares that May Yet Be Purchased Under the Plans or Programs (3)
July 1-31, 2015	—	$	—	—	—	$	—	—	$	67,276,553
August 1-31, 2015	—	—		—	—	—		—	67,276,553
September 1-30, 2015	—	—		—	—	—		—	67,276,553
Total	—	$	—	—	—	$	—	—	$	67,276,553

⁽¹⁾  Repurchases are based on the date the shares were traded. This presentation differs from the consolidated statement of cash flows, where the cost of share repurchases is based on the date the transactions were settled.

⁽²⁾  Amounts listed for average price paid per share include broker commissions paid in the transactions.

⁽³⁾  A stock repurchase plan, which was authorized by our Board of Directors, became effective and was publicly announced on November 5, 2013. This stock repurchase plan authorized the purchase of up to $100 million in common and/or preferred stock in open market or privately negotiated transactions, subject to market conditions and other factors. This stock repurchase program was replaced in November 2015 when our Board of Directors approved a new authorization for the purchase of up to $100 million in common and/or preferred stock through November 15, 2017, or when we have exhausted the funds authorized for the program.

30

ITEM 6.   EXHIBITS

12	Ratio of Earnings to Fixed Charges, and Ratio of Earnings to Combined Fixed Charges and Preference Dividends.*
31.1	Certification of Chief Executive Officer Pursuant to Section 302 of Sarbanes-Oxley Act of 2002.*
31.2	Certification of Chief Financial Officer Pursuant to Section 302 of Sarbanes-Oxley Act of 2002.*
32.1	Certification of Chief Executive Officer Pursuant to 18 U.S.C. Section 1350.*
32.2	Certification of Chief Financial Officer Pursuant to 18 U.S.C. Section 1350.*
101	Interactive Data File (Quarterly Report on Form 10-Q, for the quarterly period ended September 30, 2015, formatted in XBRL (eXtensible Business Reporting Language)).*
	Attached as Exhibit 101 to this report are the following documents formatted in XBRL: (i) the Consolidated Statements of Income and Comprehensive Income for the three and six months ended September 30, 2015 and 2014, (ii) the Consolidated Balance Sheets at September 30, 2015, September 30, 2014 and March 31, 2015, (iii) the Consolidated Statements of Cash Flows for the six months ended September 30, 2015 and 2014 and (iv) the Notes to Consolidated Financial Statements.

__________

*Filed herewith

31

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

Date:	November 5, 2015	UNIVERSAL CORPORATION
		(Registrant)
		/s/ David C. Moore
		David C. Moore, Senior Vice President and Chief Financial Officer
		(Principal Financial Officer)
		/s/ Robert M. Peebles
		Robert M. Peebles, Vice President and Controller
		(Principal Accounting Officer)

32

Exhibit Index

Exhibit No.	Description
12	Ratio of Earnings to Fixed Charges, and Ratio of Earnings to Combined Fixed Charges and Preference Dividends.*
31.1	Certification of Chief Executive Officer Pursuant to Section 302 of Sarbanes-Oxley Act of 2002.*
31.2	Certification of Chief Financial Officer Pursuant to Section 302 of Sarbanes-Oxley Act of 2002.*
32.1	Certification of Chief Executive Officer Pursuant to 18 U.S.C. Section 1350.*
32.2	Certification of Chief Financial Officer Pursuant to 18 U.S.C. Section 1350.*
101	Interactive Data File (Quarterly Report on Form 10-Q, for the quarterly period ended September 30, 2015, formatted in XBRL (eXtensible Business Reporting Language)).*
	Attached as Exhibit 101 to this report are the following documents formatted in XBRL: (i) the Consolidated Statements of Income and Comprehensive Income for the three and six months ended September 30, 2015 and 2014, (ii) the Consolidated Balance Sheets at September 30, 2015, September 30, 2014 and March 31, 2015, (iii) the Consolidated Statements of Cash Flows for the six months ended September 30, 2015 and 2014 and (iv) the Notes to Consolidated Financial Statements.

__________

*Filed herewith

33

EX-12.0

Exhibit 12

UNIVERSAL CORPORATION

RATIO OF EARNINGS TO FIXED CHARGES

AND

RATIO OF EARNINGS TO COMBINED FIXED CHARGES AND PREFERENCE DIVIDENDS

	Three Months Ended September 30,				Six Months Ended September 30,
(in thousands, except for ratios)	2015		2014		2015		2014
Earnings
Pretax income before equity in pretax earnings of unconsolidated affiliates	$	33,577	$	17,127	$	24,636	$	5,013
Fixed charges (net of interest capitalized)	4,599		5,592		9,150		10,349
Distribution of earnings from unconsolidated affiliates	—		—		—		—
Total Earnings	$	38,176	$	22,719	$	33,786	$	15,362
Fixed Charges and Preference Dividends
Interest expense	$	3,912	$	4,852	$	7,796	$	8,872
Interest capitalized	—		—		—		—
Amortization of premiums, discounts, and debt issuance costs	212		326		425		652
Interest component of rent expense	476		414		930		825
Total Fixed Charges	4,600		5,592		9,151		10,349
Dividends on convertible perpetual preferred stock (pretax)	5,673		5,712		11,345		11,423
Total Fixed Charges and Preference Dividends	$	10,273	$	11,304	$	20,496	$	21,772
Ratio of Earnings to Fixed Charges	8.30		4.06		3.69		1.48
Ratio of Earnings to Combined Fixed Charges and Preference Dividends	3.72		2.01		1.65		0.71

EX-31.1

Exhibit 31.1

CERTIFICATION

I, George C. Freeman, III, certify that:

1. I have reviewed this Quarterly Report on Form 10-Q of Universal Corporation for the period ended September 30, 2015;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

(c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of the annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5. The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: November 5, 2015	/s/ George C. Freeman, III
	George C. Freeman, III
	Chairman, President, and Chief Executive Officer
	(Principal Executive Officer)

EX-31.2

Exhibit 31.2

CERTIFICATION

I, David C. Moore, certify that:

1. I have reviewed this Quarterly Report on Form 10-Q of Universal Corporation for the period ended September 30, 2015;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

(c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of the annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5. The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: November 5, 2015	/s/ David C. Moore
	David C. Moore
	Senior Vice President and Chief Financial Officer
	(Principal Financial Officer)

EX-32.1

Exhibit 32.1

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the quarterly report of Universal Corporation (the “Company”) on Form 10-Q for the period ended September 30, 2015 as filed with the Securities and Exchange Commission on the date hereof (the “Report”) and pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, I, George C. Freeman, III, certify, to the best of my knowledge and belief, that

(1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

Date: November 5, 2015	/s/ George C. Freeman, III
	George C. Freeman, III
	Chairman, President, and Chief Executive Officer
	(Principal Executive Officer)

A signed original of this written statement required by Section 906 has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.

EX-32.2

Exhibit 32.2

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the quarterly report of Universal Corporation (the “Company”) on Form 10-Q for the period ended September 30, 2015 as filed with the Securities and Exchange Commission on the date hereof (the “Report”) and pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, I, David C. Moore, certify, to the best of my knowledge and belief, that

(1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

Date: November 5, 2015	/s/ David C. Moore
	David C. Moore
	Senior Vice President and Chief Financial Officer
	(Principal Financial Officer)

A signed original of this written statement required by Section 906 has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.

XML

Pension And Other Postretirement Benefit Plans Pension And Other Postretirement Benefit Plans (Narrative) (Details) $ in Millions	6 Months Ended
	Sep. 30, 2015 USD ($)
Pension and Other Postretirement Benefits [Line Items]
Contributions to qualified and non-qualified pension plans	$ 3.8
Expected additional contributions in the current fiscal year	8.6
ERISA-regulated U.S. plan [Member]
Pension and Other Postretirement Benefits [Line Items]
Expected additional contributions in the current fiscal year	2.7
Non-ERISA regulated and Other Plans [Member]
Pension and Other Postretirement Benefits [Line Items]
Expected additional contributions in the current fiscal year	$ 5.9

XML

Derivatives And Hedging Activities Notional Amount of Forward Contracts (Details) - USD ($) $ in Millions	Sep. 30, 2015	Sep. 30, 2014
Derivatives Designated As Hedges [Member] | Forward contracts related to tobacco purchases [Member]
Derivative [Line Items]
Notional amount of derivative contracts	$ 19.8	$ 53.8
Derivatives Not Designated As Hedges [Member] | Forward contracts related to tobacco processing costs [Member]
Derivative [Line Items]
Notional amount of derivative contracts	5.6	12.3
Forward Foreign Currency Exchange Contract [Member]
Derivative [Line Items]
Notional amount of derivative contracts	$ 25.4	$ 66.1

XML

Accumulated Other Comprehensive Income (Loss) Accumulated Other Comprehensive Income (Loss) (Tables)

6 Months Ended

Sep. 30, 2015

Accumulated Other Comprehensive Income (Loss), Net of Tax [Abstract]

Schedule of Accumulated Other Comprehensive Income (Loss)

The following table summarizes the changes in the accumulated balances for each component of accumulated other comprehensive income (loss) attributable to the Company for the six months ended September 30, 2015 and 2014:

	Six Months Ended September 30,
(in thousands of dollars)	2015			2014
Foreign currency translation:
Balance at beginning of year	$	(31,138	)	$	(8,476	)
Other comprehensive income (loss) attributable to Universal Corporation:
Net gain (loss) on foreign currency translation (net of tax (expense) benefit of $(1,155) and $4,921)	2,147			(9,138		)
Less: Net gain (loss) on foreign currency translation attributable to noncontrolling interests	426			(37		)
Other comprehensive income (loss) attributable to Universal Corporation, net of income taxes	2,573			(9,175		)
Balance at end of period	$	(28,565	)	$	(17,651	)
Foreign currency hedge:
Balance at beginning of year	$	(1,834	)	$	769
Other comprehensive income (loss) attributable to Universal Corporation:
Net gain (loss) on derivative instruments (net of tax (expense) benefit of $(878) and $571)	1,629			(1,060		)
Reclassification of gain to earnings (net of tax expense of $90 and $385)(1)	(166		)	(715		)
Other comprehensive income (loss) attributable to Universal Corporation, net of income taxes	1,463			(1,775		)
Balance at end of period	$	(371	)	$	(1,006	)
Interest rate hedge:
Balance at beginning of year	$	(1,982	)	$	(608	)
Other comprehensive income (loss) attributable to Universal Corporation:
Net loss on derivative instruments (net of tax benefit of $2,120 and $38)	(3,937		)	(69		)
Reclassification of loss to earnings (net of tax benefit of $(936) and $(142))(2)	1,740			263
Other comprehensive income (loss) attributable to Universal Corporation, net of income taxes	(2,197		)	194
Balance at end of period	$	(4,179	)	$	(414	)
Pension and other postretirement benefit plan:
Balance at beginning of year	$	(40,040	)	$	(26,017	)
Other comprehensive income (loss) attributable to Universal Corporation:
Amortization included in earnings (net of tax benefit of $(844) and $(550)) (3)	1,498			1,087
Other comprehensive income (loss) attributable to Universal Corporation, net of income taxes	1,498			1,087
Balance at end of period	$	(38,542	)	$	(24,930	)
Total accumulated other comprehensive income (loss) at end of period	$	(71,657	)	$	(44,001	)

⁽¹⁾ Gain (loss) on foreign currency cash flow hedges related to forecast purchases of tobacco is reclassified from accumulated other comprehensive income (loss) to cost of goods sold when the tobacco is sold to customers. See Note 7 for additional information.

⁽²⁾ Gain (loss) on interest rate cash flow hedges is reclassified from accumulated other comprehensive income (loss) to interest expense when the related interest payments are made on the debt or upon termination of the interest rate swap agreements prior to their scheduled maturity dates. See Note 7 for additional information.

⁽³⁾ This accumulated other comprehensive income (loss) component is included in the computation of net periodic benefit cost. See Note 9 for additional information.

XML

Stock-Based Compensation (Stock-Based Awards Issued During The Period) (Details) - $ / shares	6 Months Ended
	Sep. 30, 2015	Sep. 30, 2014
Restricted Stock Units (RSUs) [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number granted	67,750	79,950
Grant date fair value	$ 52.10	$ 52.78
Performance Share Awards (PSAs) [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number granted	57,750	48,450
Grant date fair value	$ 45.06	$ 46.41

XML

Fair Value Measurements (Financial Assets And Liabilities Measured At Fair Value On Recurring Basis) (Details) - USD ($) $ in Thousands	Sep. 30, 2015	Mar. 31, 2015	Sep. 30, 2014
Assets:
Money market funds	$ 1,574	$ 86,552	$ 1,527
Trading securities associated with deferred compensation plans	18,359	20,692	20,039
Forward foreign currency exchange contracts	4,354	5,254	5,172
Total financial assets measured and reported at fair value	24,287	112,498	26,738
Liabilities:
Guarantees of bank loans to tobacco growers	1,356	1,674	1,797
Interest rate swap agreements	6,430	3,050	638
Forward foreign currency exchange contracts	13	579	109
Total financial liabilities measured and reported at fair value	7,799	5,303	2,544
Level 1 [Member]
Assets:
Money market funds	0	0	0
Trading securities associated with deferred compensation plans	18,359	20,692	20,039
Forward foreign currency exchange contracts	0	0	0
Total financial assets measured and reported at fair value	18,359	20,692	20,039
Liabilities:
Guarantees of bank loans to tobacco growers	0	0	0
Interest rate swap agreements	0	0	0
Forward foreign currency exchange contracts	0	0	0
Total financial liabilities measured and reported at fair value	0	0	0
Level 2 [Member]
Assets:
Money market funds	1,574	86,552	1,527
Trading securities associated with deferred compensation plans	0	0	0
Forward foreign currency exchange contracts	4,354	5,254	5,172
Total financial assets measured and reported at fair value	5,928	91,806	6,699
Liabilities:
Guarantees of bank loans to tobacco growers	0	0	0
Interest rate swap agreements	6,430	3,050	638
Forward foreign currency exchange contracts	13	579	109
Total financial liabilities measured and reported at fair value	6,443	3,629	747
Level 3 [Member]
Assets:
Money market funds	0	0	0
Trading securities associated with deferred compensation plans	0	0	0
Forward foreign currency exchange contracts	0	0	0
Total financial assets measured and reported at fair value	0	0	0
Liabilities:
Guarantees of bank loans to tobacco growers	1,356	1,674	1,797
Interest rate swap agreements	0	0	0
Forward foreign currency exchange contracts	0	0	0
Total financial liabilities measured and reported at fair value	$ 1,356	$ 1,674	$ 1,797

XML

Restructuring Costs Restructuring Costs

6 Months Ended

Sep. 30, 2015

Restructuring Costs [Abstract]

Restructuring Costs

RESTRUCTURING AND IMPAIRMENT COSTS

Universal continually reviews its business for opportunities to realize efficiencies, reduce costs, and realign its operations in response to business changes. Restructuring and impairment costs are periodically incurred in connection with those activities.     For the reporting periods ended September 30, 2015 and 2014, all restructuring costs incurred related to operations that are part of the Other Regions reportable segment of the Company's Flue-Cured and Burley Tobacco Operations.

Six Months Ended September 30, 2015

In the first quarter of fiscal year 2016, the Company recorded restructuring and impairment costs totaling $2.4 million related to plans to significantly scale back its operations in Zambia. Those costs included statutory employee termination benefits, impairment charges related to outstanding balances on loans to farmers whose contracts were terminated as a result of the decision, and impairment charges on certain property and equipment. The total restructuring liability related to these costs at September 30, 2015, was $1.6 million, the majority of which the Company expects will be paid before the end of the current fiscal year.

Three andSix Months Ended September 30, 2014

In the second quarter of fiscal year 2015, the Company announced plans to suspend its operations in Argentina. In connection with that decision, during the quarter ended September 30, 2014, the Company's subsidiary in Argentina incurred costs related to employee terminations, as well as costs related to exiting its business arrangements with a supplier. Substantially all operations in Argentina were discontinued effective December 31, 2014. The Company also initiated and completed a program to downsize certain functions at its operations in Brazil during the quarter and recorded employee termination costs in connection with that initiative. Restructuring costs recorded in Argentina and Brazil totaled approximately $3.4 million on a consolidated basis, all of which was paid by the end of fiscal year 2015.

XML

Operating Segments (Operating Results For The Company's Reportable Segments) (Details) - USD ($) $ in Thousands		3 Months Ended					6 Months Ended
		Sep. 30, 2015		Jun. 30, 2015	Sep. 30, 2014		Sep. 30, 2015		Sep. 30, 2014
Segment Reporting Information [Line Items]
Sales and other operating revenues		$ 456,382			$ 464,116		$ 731,801		$ 735,588
Deduct: Equity in pretax loss (earnings) of unconsolidated affiliates	[1]	(846)			(3,317)		(230)		(3,918)
Restructuring and impairment costs		0	[2]	$ (2,400)	(3,350)	[2]	(2,389)	[2]	(3,350)	[2]
Consolidated operating income (loss)		37,284			21,912		31,988		13,675
Operating Segments [Member]
Segment Reporting Information [Line Items]
Consolidated operating income (loss)		38,130			28,579		34,607		20,943
Flue-Cured And Burley Leaf Tobacco Operations [Member]
Segment Reporting Information [Line Items]
Sales and other operating revenues		420,453			424,977		646,426		654,247
Consolidated operating income (loss)		37,985			25,939		33,554		17,043
Other Tobacco Operations [Member]
Segment Reporting Information [Line Items]
Sales and other operating revenues	[3]	35,929			39,139		85,375		81,341
Consolidated operating income (loss)	[3]	145			2,640		1,053		3,900
North America [Member] | Flue-Cured And Burley Leaf Tobacco Operations [Member]
Segment Reporting Information [Line Items]
Sales and other operating revenues		49,421			53,308		97,993		85,006
Consolidated operating income (loss)		3,783			4,278		7,199		5,957
Other Regions [Member] | Flue-Cured And Burley Leaf Tobacco Operations [Member]
Segment Reporting Information [Line Items]
Sales and other operating revenues	[4]	371,032			371,669		548,433		569,241
Consolidated operating income (loss)	[4]	$ 34,202			$ 21,661		$ 26,355		$ 11,086

[1] Equity in pretax earnings of unconsolidated affiliates is included in segment operating income (Other Tobacco Operations segment), but is reported below consolidated operating income and excluded from that total in the consolidated statements of income and comprehensive income.

[2] Restructuring and impairment costs are excluded from segment operating income, but are included in consolidated operating income in the consolidated statements of income and comprehensive income.

[3] Includes Dark Air-Cured, Special Services, and Oriental, as well as inter-company eliminations. Sales and other operating revenues for this reportable segment include limited amounts for Oriental because its financial results consist principally of equity in the pretax earnings of an unconsolidated affiliate.

[4] Includes South America, Africa, Europe, and Asia regions, as well as inter-region eliminations.

XML

Earnings Per Share (Computation Of Basic And Diluted Earnings (Loss) Per Share) (Details) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended		6 Months Ended
	Sep. 30, 2015	Sep. 30, 2014	Sep. 30, 2015	Sep. 30, 2014
Numerator for basic earnings per share
Net income attributable to Universal Corporation	$ 22,465	$ 15,025	$ 16,518	$ 15,742
Less: Dividends on convertible perpetual preferred stock	(3,687)	(3,713)	(7,374)	(7,425)
Earnings available to Universal Corporation common shareholders	$ 18,778	$ 11,312	$ 9,144	$ 8,317
Denominator for basic earnings per share
Weighted average shares outstanding	22,675,323	23,178,082	22,649,270	23,200,589
Basic earnings (loss) per share	$ 0.83	$ 0.49	$ 0.40	$ 0.36
Numerator for diluted earnings per share
Earnings available to Universal Corporation common shareholders	$ 18,778	$ 11,312	$ 9,144	$ 8,317
Add: Dividends on convertible perpetual preferred stock (if conversion assumed)	3,687	0	0	0
Earnings available to Universal Corporation common shareholders for calculation of diluted earnings per share	$ 22,465	$ 11,312	$ 9,144	$ 8,317
Denominator for diluted earnings per share:
Weighted average shares outstanding	22,675,323	23,178,082	22,649,270	23,200,589
Incremental Common Shares Attributable to Dilutive Effect of Conversion of Preferred Stock	4,848,766	0	0	0
Incremental Common Shares Attributable to Dilutive Effect of Share-based Payment Arrangements	326,539	330,445	287,361	320,982
Denominator for diluted earnings per share	27,850,628	23,508,527	22,936,631	23,521,571
Diluted earnings per share	$ 0.81	$ 0.48	$ 0.40	$ 0.35

XML

Restructuring Costs Restructuring costs (Narrative) (Details) - USD ($) $ in Thousands	3 Months Ended					6 Months Ended
	Sep. 30, 2015		Jun. 30, 2015	Sep. 30, 2014	[1]	Sep. 30, 2015		Sep. 30, 2014	[1]
Restructuring Costs [Line Items]
Restructuring and impairment costs	$ 0	[1]	$ 2,400	$ 3,350		$ 2,389	[1]	$ 3,350
Restructuring liability	$ 1,600					$ 1,600

[1] Restructuring and impairment costs are excluded from segment operating income, but are included in consolidated operating income in the consolidated statements of income and comprehensive income.

XML

Accumulated Other Comprehensive Income (Loss) (Narrative) (Details) - USD ($) $ in Thousands		6 Months Ended
		Sep. 30, 2015	Sep. 30, 2014	Mar. 31, 2015
Other Comprehensive Income (Loss), Tax [Abstract]
Accumulated other comprehensive loss		$ (71,657)	$ (44,001)	$ (74,994)
Accumulated Translation Adjustment [Member]
Foreign currency translation: [Abstract]
Balance at beginning of year		(31,138)	(8,476)
Net gain (loss) on foreign currency translation, net of income taxes		2,147	(9,138)
Less: Net loss (gain) on foreign currency translation attributable to noncontrolling interests		426	(37)
Other comprehensive income (loss) attributable to Universal Corporation, net of income taxes		2,573	(9,175)
Balance at end of period		(28,565)	(17,651)
Other Comprehensive Income (Loss), Tax [Abstract]
Taxes on net gain (loss) on foreign currency translation		(1,155)	4,921
Accumulated Net Gain (Loss) from Designated or Qualifying Cash Flow Hedges [Member] | Forward Foreign Currency Exchange Contract [Member]
Cash flow hedges: [Abstract]
Balance at beginning of year		(1,834)	769
Net gain (loss) on derivative instruments, net of income taxes		1,629	(1,060)
Reclassifications to earnings, net of income taxes	[1]	(166)	(715)
Other comprehensive income (loss) attributable to Universal Corporation, net of income taxes		1,463	(1,775)
Balance at end of period		(371)	(1,006)
Other Comprehensive Income (Loss), Tax [Abstract]
Taxes on net gain (loss) on derivative instruments		(878)	571
Taxes on reclassifications to net income		90	385
Accumulated Net Gain (Loss) from Designated or Qualifying Cash Flow Hedges [Member] | Interest Rate Swap [Member]
Cash flow hedges: [Abstract]
Balance at beginning of year		(1,982)	(608)
Net gain (loss) on derivative instruments, net of income taxes		(3,937)	(69)
Reclassifications to earnings, net of income taxes	[2]	1,740	263
Other comprehensive income (loss) attributable to Universal Corporation, net of income taxes		(2,197)	194
Balance at end of period		(4,179)	(414)
Other Comprehensive Income (Loss), Tax [Abstract]
Taxes on net gain (loss) on derivative instruments		2,120	38
Taxes on reclassifications to net income		(936)	(142)
Accumulated Defined Benefit Plans Adjustment [Member]
Pension and other postretirement benefit plan: [Abstract]
Balance at beginning of year		(40,040)	(26,017)
Amortization included in earnings, net of income taxes	[3]	1,498	1,087
Other comprehensive income (loss) attributable to Universal Corporation, net of income taxes		1,498	1,087
Balance at end of period		(38,542)	(24,930)
Other Comprehensive Income (Loss), Tax [Abstract]
Taxes on amortization included in net income		$ (844)	$ (550)

[1] Gain (loss) on foreign currency cash flow hedges related to forecast purchases of tobacco is reclassified from accumulated other comprehensive income (loss) to cost of goods sold when the tobacco is sold to customers. See Note 7 for additional information.

[2] Gain (loss) on interest rate cash flow hedges is reclassified from accumulated other comprehensive income (loss) to interest expense when the related interest payments are made on the debt or upon termination of the interest rate swap agreements prior to their scheduled maturity dates. See Note 7 for additional information.

[3] This accumulated other comprehensive income (loss) component is included in the computation of net periodic benefit cost. See Note 9 for additional information.

XML

Earnings Per Share (Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share (Details) shares in Thousands	6 Months Ended
	Sep. 30, 2015 shares	Sep. 30, 2014 shares
Earnings Per Share [Abstract]
Potentially dilutive securities	133,600	169,000
Weighted-average exercise price	62.66	62.66

XML

Income Taxes (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Sep. 30, 2015	Sep. 30, 2014	Sep. 30, 2015	Sep. 30, 2014
Income Tax Disclosure [Line Items]
Federal statutory income tax rate	35.00%	35.00%
Effective income tax rate	27.00%	24.00%
Consolidated income tax expense (benefit)	$ 9,359	$ 4,960	$ 5,927	$ (7,078)
Effective Income Tax Rate Reconciliation excluding European Commission fine [Member]
Income Tax Disclosure [Line Items]
Effective income tax rate			24.00%	10.00%
Deltafina [Member]
Income Tax Disclosure [Line Items]
Consolidated income tax expense (benefit)		$ 8,000

XML

Guarantees, Other Contingent Liabilities, And Other Matters

6 Months Ended

Sep. 30, 2015

Guarantees, Other Contingent Liabilities, And Other Matters [Abstract]

Guarantees, Other Contingent Liabilities, And Other Matters

GUARANTEES, OTHER CONTINGENT LIABILITIES, AND OTHER MATTERS

Guarantees and Other Contingent Liabilities

Guarantees of Bank Loans and Other Contingent Liabilities

Guarantees of bank loans to tobacco growers for crop financing and construction of curing barns or other tobacco producing assets have long been industry practice in Brazil and support the farmers’ production of tobacco there. At September 30, 2015, the Company’s total exposure under guarantees issued by its operating subsidiary for banking facilities of farmers in Brazil was approximately $25 million ($26 million face amount including unpaid accrued interest, less $1 million recorded for the fair value of the guarantees). All of these guarantees expire within one year. The subsidiary withholds payments due to the farmers on delivery of tobacco and forwards those payments to the third-party banks. Failure of farmers to deliver sufficient quantities of tobacco to the subsidiary to cover its obligations to the third-party banks could result in a liability for the subsidiary under the related guarantees; however, in that case, the subsidiary would have recourse against the farmers. The maximum potential amount of future payments that the Company’s subsidiary could be required to make at September 30, 2015, was the face amount, $26 million including unpaid accrued interest ($35 million at September 30, 2014, and $17 million at March 31, 2015). The fair value of the guarantees was a liability of approximately $1 million at September 30, 2015 ($2 million at September 30, 2014, and $2 million at March 31, 2015). In addition to these guarantees, the Company has other contingent liabilities, primarily related to outstanding letters of credit, totaling approximately $3 million at September 30, 2015.

Value-Added Tax Assessments in Brazil

As further discussed below, the Company’s local operating subsidiaries pay significant amounts of value-added tax (“VAT”) in connection with their normal operations. In Brazil, VAT is assessed at the state level when green tobacco is transferred between states. The Company’s operating subsidiary there pays VAT when tobaccos grown in the states of Santa Catarina and Parana are transferred to its factory in the state of Rio Grande do Sul for processing. The subsidiary has received assessments for additional VAT plus interest and penalties from tax authorities for the states of Santa Catarina and Parana based on audits of the subsidiary’s VAT filings for specified periods. In June 2011, tax authorities for the state of Santa Catarina issued assessments for tax, interest, and penalties for periods from 2006 through 2009 totaling approximately $12 million. In September 2014, tax authorities for the state of Parana issued an assessment for tax, interest, and penalties for periods from 2009 through 2014 totaling approximately $14 million. Those amounts are based on the exchange rate for the Brazilian currency at September 30, 2015. Management of the operating subsidiary and outside counsel believe that errors were made by the tax authorities for both states in determining all or significant portions of these assessments and that various defenses support the subsidiary’s positions.

With respect to the Santa Catarina assessments, the subsidiary took appropriate steps to contest the full amount of the claims. As of September 30, 2015, a portion of the subsidiary’s arguments had been accepted, and the outstanding assessment had been reduced. The reduced assessment, together with the related accumulated interest through the end of the current reporting period, totaled approximately $10 million (at the September 30, 2015 exchange rate). The subsidiary is continuing to contest the full remaining amount of the assessment. While the range of reasonably possible loss is zero up to the full $10 million remaining assessment, based on the strength of the subsidiary’s defenses, no loss within that range is considered probable at this time and no liability has been recorded at September 30, 2015.

With respect to the Parana assessment, management of the subsidiary and outside counsel have undertaken the steps required to contest the full amount of the claim. A significant portion of the Parana assessment is based on positions taken by the tax authorities that management and outside counsel believe deviate significantly from the underlying statutes and relevant case law. In addition, under the law, the subsidiary’s tax filings for certain periods covered in the assessment were no longer open to any challenge by the tax authorities. On that basis, the range of reasonably possible loss is considered to be zero up to a maximum of $12 million (including accumulated interest), rather than the full amount of the assessment. Based on the strength of the subsidiary's defenses, no loss within that range is considered probable at this time and no liability has been recorded at September 30, 2015.

In both states, the process for reaching a final resolution to the assessments is expected to be lengthy, and management is not currently able to predict when either case will be concluded. Should the subsidiary ultimately be required to pay any tax, interest, or penalties in either case, the portion paid for tax would generate value-added tax credits that the subsidiary may be able to recover.

Other Legal and Tax Matters

Various subsidiaries of the Company are involved in other litigation and tax examinations incidental to their business activities.  While the outcome of these matters cannot be predicted with certainty, management is vigorously defending the matters and does not currently expect that any of them will have a material adverse effect on the Company’s business or financial position.  However, should one or more of these matters be resolved in a manner adverse to management’s current expectation, the effect on the Company’s results of operations for a particular fiscal reporting period could be material.

Advances to Suppliers

In many sourcing origins where the Company operates, it provides agronomy services and seasonal advances of seed, fertilizer, and other supplies to tobacco farmers for crop production, or makes seasonal cash advances to farmers for the procurement of those inputs. These advances are short term, are repaid upon delivery of tobacco to the Company, and are reported in advances to suppliers in the consolidated balance sheets. In several origins, the Company has made long-term advances to tobacco farmers to finance curing barns and other farm infrastructure. In some years, due to low crop yields and other factors, individual farmers may not deliver sufficient volumes of tobacco to fully repay their seasonal advances, and the Company may extend repayment of those advances into future crop years. The long-term portion of advances is included in other noncurrent assets in the consolidated balance sheets. Both the current and the long-term portions of advances to suppliers are reported net of allowances recorded when the Company determines that amounts outstanding are not likely to be collected. Short-term and long-term advances to suppliers totaled $71 million at September 30, 2015, $115 million at September 30, 2014, and $156 million at March 31, 2015. The related valuation allowances totaled $27 million at September 30, 2015, $38 million at September 30, 2014, and $35 million at March 31, 2015, and were estimated based on the Company’s historical loss information and crop projections. The allowances were reduced by net recoveries of approximately $4 million and $2 million in the six-month periods ended September 30, 2015 and 2014, respectively. These net recoveries are included in selling, general, and administrative expenses in the consolidated statements of income. Interest on advances is recognized in earnings upon the farmers’ delivery of tobacco in payment of principal and interest.

Recoverable Value-Added Tax Credits

In many foreign countries, the Company’s local operating subsidiaries pay significant amounts of value-added tax (“VAT”) on purchases of unprocessed and processed tobacco, crop inputs, packing materials, and various other goods and services. In some countries, VAT is a national tax, and in other countries it is assessed at the state level. Items subject to VAT vary from jurisdiction to jurisdiction, as do the rates at which the tax is assessed. When tobacco is sold to customers in the country of origin, the operating subsidiaries generally collect VAT on those sales. The subsidiaries are normally permitted to offset their VAT payments against the collections and remit only the incremental VAT collections to the tax authorities. When tobacco is sold for export, VAT is normally not assessed. In countries where tobacco sales are predominately for export markets, VAT collections generated on downstream sales are often not sufficient to fully offset the subsidiaries’ VAT payments. In those situations, unused VAT credits can accumulate. Some jurisdictions have procedures that allow companies to apply for refunds of unused VAT credits from the tax authorities, but the refund process often takes an extended period of time and it is not uncommon for refund applications to be challenged or rejected in part on technical grounds. Other jurisdictions may permit companies to sell or transfer unused VAT credits to third parties in private transactions, although approval for such transactions must normally be obtained from the tax authorities, limits on the amounts that can be transferred may be imposed, and the proceeds realized may be heavily discounted from the face value of the credits. Due to these factors, local operating subsidiaries in some countries can accumulate significant balances of VAT credits over time. The Company reviews these balances on a regular basis and records valuation allowances on the credits to reflect amounts that are not expected to be recovered, as well as discounts anticipated on credits that are expected to be sold or transferred. At September 30, 2015, the aggregate balance of recoverable tax credits held by the Company’s subsidiaries totaled approximately $52 million ($69 million at September 30, 2014, and $60 million at March 31, 2015), and the related valuation allowances totaled approximately $21 million ($37 million at September 30, 2014, and $23 million at March 31, 2015). The net balances are reported in other current assets and other noncurrent assets in the consolidated balance sheets.

XML

Derivatives And Hedging Activities (Narrative) (Details) - USD ($) $ in Millions	6 Months Ended
	Sep. 30, 2015	Mar. 31, 2015	Dec. 31, 2014	Sep. 30, 2014
Derivative [Line Items]
Net unrealized gain on foreign currency derivatives designated as cash flow hedges	$ 0.6
Foreign Exchange Forward [Member]
Derivative [Line Items]
Notional amount of derivative contracts	114.0	$ 80.4		$ 89.8
Cash Flow Hedging [Member] | Interest Rate Swap [Member]
Derivative [Line Items]
Notional amount of derivative contracts	$ 370.0		$ 74.0

XML

Pension And Other Postretirement Benefit Plans (Components Of Company's Net Periodic Benefit Cost) (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Sep. 30, 2015	Sep. 30, 2014	Sep. 30, 2015	Sep. 30, 2014
Pension Benefits [Member]
Defined Benefit Plan Disclosure [Line Items]
Service cost	$ 1,479	$ 1,327	$ 2,962	$ 2,661
Interest cost	2,347	2,656	4,693	5,325
Expected return on plan assets	(3,577)	(3,535)	(7,153)	(7,227)
Curtailment gain	0	0	0	0
Net amortization and deferral	1,199	780	2,398	1,560
Net periodic benefit cost	1,448	1,228	2,900	2,319
Other Postretirement Benefits [Member]
Defined Benefit Plan Disclosure [Line Items]
Service cost	106	114	214	228
Interest cost	392	481	799	965
Expected return on plan assets	(15)	(26)	(30)	(52)
Curtailment gain	0	(1,503)	0	(1,503)
Net amortization and deferral	(44)	(133)	(88)	(266)
Net periodic benefit cost	$ 439	$ (1,067)	$ 895	$ (628)

XML

Consolidated Statements Of Income And Comprehensive Income - USD ($) $ in Thousands		3 Months Ended		6 Months Ended
		Sep. 30, 2015	Sep. 30, 2014	Sep. 30, 2015	Sep. 30, 2014
Sales and other operating revenues		$ 456,382	$ 464,116	$ 731,801	$ 735,588
Costs and Expenses
Cost of goods sold		358,288	379,045	585,318	594,977
Selling, general and administrative expenses		60,810	59,809	112,106	123,586
Restructuring and impairment costs	[1]	0	3,350	2,389	3,350
Operating income		37,284	21,912	31,988	13,675
Equity in pretax earnings (loss) of unconsolidated affiliates	[2]	846	3,317	230	3,918
Interest income		205	67	444	210
Interest expense		3,912	4,852	7,796	8,872
Income before income taxes		34,423	20,444	24,866	8,931
Income tax expense (benefit)		9,359	4,960	5,927	(7,078)
Net income		25,064	15,484	18,939	16,009
Less: net income attributable to noncontrolling interests in subsidiaries		(2,599)	(459)	(2,421)	(267)
Net income attributable to Universal Corporation		22,465	15,025	16,518	15,742
Dividends on Universal Corporation convertible perpetual preferred stock		(3,687)	(3,713)	(7,374)	(7,425)
Earnings available to Universal Corporation common shareholders		$ 18,778	$ 11,312	$ 9,144	$ 8,317
Earnings per share attributable to Universal Corporation common shareholders:
Basic		$ 0.83	$ 0.49	$ 0.40	$ 0.36
Diluted		$ 0.81	$ 0.48	$ 0.40	$ 0.35
Weighted average common shares outstanding:
Basic		22,675,323	23,178,082	22,649,270	23,200,589
Diluted		27,850,628	23,508,527	22,936,631	23,521,571
Total comprehensive income:
Total comprehensive income, net of income taxes		$ 19,470	$ 4,954	$ 21,850	$ 6,303
Less: comprehensive (income) loss attributable to noncontrolling interests, net of income taxes		(2,259)	(178)	(1,995)	(230)
Comprehensive income attributable to Universal Corporation, net of income taxes		$ 17,211	$ 4,776	$ 19,855	$ 6,073
Dividends declared per common share		$ 0.52	$ 0.51	$ 1.04	$ 1.02

[1] Restructuring and impairment costs are excluded from segment operating income, but are included in consolidated operating income in the consolidated statements of income and comprehensive income.

[2] Equity in pretax earnings of unconsolidated affiliates is included in segment operating income (Other Tobacco Operations segment), but is reported below consolidated operating income and excluded from that total in the consolidated statements of income and comprehensive income.

XML

Changes In Shareholders' Equity And Noncontrolling Interests In Subsidiaries (Reconciliation Of Changes In Shareholders' Equity And Noncontrolling Interests In Subsidiaries) (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Sep. 30, 2015	Sep. 30, 2014	Sep. 30, 2015	Sep. 30, 2014
Schedule of Capitalization, Equity [Line Items]
Total stockholders' equity attributable to parent, beginning balance			$ 1,362,725
Noncontrolling interests in subsidiaries, beginning balance			34,369
Total shareholders' equity, beginning balance			1,397,094	$ 1,410,892
Issuance of common stock			0	187
Repurchase of stock			0	(1,143)
Accrual of stock-based compensation			3,020	3,755
Withholding of shares from stock-based compensation for grantee income taxes (SARs, RSUs, and PSAs)			(2,037)	(2,009)
Dividend equivalents on RSUs			364	316
Net income (loss) attributable to parent	$ 22,465	$ 15,025	16,518	15,742
Net income (loss) attributable to noncontrolling interest	2,599	459	2,421	267
Net income	25,064	15,484	18,939	16,009
Series B 6.75% convertible perpetual preferred stock dividends declared			(7,374)	(7,425)
Common stock dividends declared			(23,582)	(23,644)
Repurchase of stock, retained earnings			0	(6,059)
Dividend equivalents on RSUs			(364)	(316)
Other comprehensive income (loss)			2,911	(9,706)
Dividends paid to noncontrolling interests			(1,260)	(1,977)
Total stockholders' equity attributable to parent, ending balance	1,352,607	1,347,965	1,352,607	1,347,965
Noncontrolling interest in subsidiaries, ending balance	35,104	30,915	35,104	30,915
Total shareholders' equity, ending balance	1,387,711	1,378,880	1,387,711	1,378,880
Universal Corporation [Member]
Schedule of Capitalization, Equity [Line Items]
Total stockholders' equity attributable to parent, beginning balance			1,362,725	1,378,230
Issuance of common stock			0	187
Repurchase of stock			0	(1,143)
Accrual of stock-based compensation			3,020	3,755
Withholding of shares from stock-based compensation for grantee income taxes (SARs, RSUs, and PSAs)			(2,037)	(2,009)
Dividend equivalents on RSUs			364	316
Net income (loss) attributable to parent			16,518	15,742
Series B 6.75% convertible perpetual preferred stock dividends declared			(7,374)	(7,425)
Common stock dividends declared			(23,582)	(23,644)
Repurchase of stock, retained earnings			0	(6,059)
Dividend equivalents on RSUs			(364)	(316)
Other comprehensive income (loss) attributable to parent			3,337	(9,669)
Dividends paid to noncontrolling interests			0	0
Total stockholders' equity attributable to parent, ending balance	1,352,607	1,347,965	1,352,607	1,347,965
Noncontrolling Interests [Member]
Schedule of Capitalization, Equity [Line Items]
Noncontrolling interests in subsidiaries, beginning balance			34,369	32,662
Issuance of common stock			0	0
Repurchase of stock			0	0
Accrual of stock-based compensation			0	0
Withholding of shares from stock-based compensation for grantee income taxes (SARs, RSUs, and PSAs)			0	0
Dividend equivalents on RSUs			0	0
Net income (loss) attributable to noncontrolling interest			2,421	267
Series B 6.75% convertible perpetual preferred stock dividends declared			0	0
Common stock dividends declared			0	0
Repurchase of stock, retained earnings			0	0
Dividend equivalents on RSUs			0	0
Other comprehensive income (loss) attributable to noncontrolling interest			(426)	(37)
Dividends paid to noncontrolling interests			(1,260)	(1,977)
Noncontrolling interest in subsidiaries, ending balance	$ 35,104	$ 30,915	$ 35,104	$ 30,915

XML

Basis Of Presentation

6 Months Ended

Sep. 30, 2015

Organization, Consolidation and Presentation of Financial Statements [Abstract]

Basis Of Presentation

BASIS OF PRESENTATION

Universal Corporation, which together with its subsidiaries is referred to herein as “Universal” or the “Company,” is the leading global leaf tobacco supplier. Because of the seasonal nature of the Company’s business, the results of operations for any fiscal quarter will not necessarily be indicative of results to be expected for other quarters or a full fiscal year. All adjustments necessary to state fairly the results for the period have been included and were of a normal recurring nature. Certain amounts in prior year statements have been reclassified to conform to the current year presentation. This Form 10-Q should be read in conjunction with the financial statements and notes thereto included in the Company’s Annual Report on Form 10-K for the fiscal year ended March 31, 2015.

XML

Derivatives And Hedging Activities (Effect Of Derivative Financial Instruments On The Consolidated Balance Sheets) (Details) - USD ($) $ in Thousands	Sep. 30, 2015	Mar. 31, 2015	Sep. 30, 2014
Derivative [Line Items]
Derivatives in a Fair Value Asset Position Designated as Hedging Instruments	$ 0	$ 106	$ 0
Derivatives in a Fair Value Liability Position Designated as Hedging Instruments	6,430	3,446	638
Derivatives in a Fair Value Asset Position Not Designated as Hedging Instruments	4,354	5,148	5,172
Derivatives in a Fair Value Liability Position Not Designated as Hedging Instruments	12	183	109
Interest Rate Swap Agreements [Member] | Other Non-Current Assets [Member]
Derivative [Line Items]
Derivatives in a Fair Value Asset Position Designated as Hedging Instruments	0	0	0
Interest Rate Swap Agreements [Member] | Other Long-Term Liabilities [Member]
Derivative [Line Items]
Derivatives in a Fair Value Liability Position Designated as Hedging Instruments	6,430	3,050	638
Forward Foreign Currency Exchange Contract [Member] | Other Current Assets [Member]
Derivative [Line Items]
Derivatives in a Fair Value Asset Position Designated as Hedging Instruments	0	106	0
Derivatives in a Fair Value Asset Position Not Designated as Hedging Instruments	4,354	5,148	5,172
Forward Foreign Currency Exchange Contract [Member] | Accounts Payable and Accrued Expenses [Member]
Derivative [Line Items]
Derivatives in a Fair Value Liability Position Designated as Hedging Instruments	0	396	0
Derivatives in a Fair Value Liability Position Not Designated as Hedging Instruments	$ 12	$ 183	$ 109

XML

Pension And Other Postretirement Benefit Plans (Tables)

6 Months Ended

Sep. 30, 2015

Defined Benefit Pension Plans and Defined Benefit Postretirement Plans Disclosure [Abstract]

Components of Company's Net Periodic Benefit Cost

The components of the Company’s net periodic benefit cost were as follows:

	Pension Benefits						Other Postretirement Benefits
	Three Months Ended September 30,						Three Months Ended September 30,
(in thousands of dollars)	2015			2014			2015			2014
Service cost	$	1,479		$	1,327		$	106		$	114
Interest cost	2,347			2,656			392			481
Expected return on plan assets	(3,577		)	(3,535		)	(15		)	(26		)
Curtailment gain	—			—			—			(1,503		)
Net amortization and deferral	1,199			780			(44		)	(133		)
Net periodic benefit cost	$	1,448		$	1,228		$	439		$	(1,067	)

	Pension Benefits						Other Postretirement Benefits
	Six Months Ended September 30,						Six Months Ended September 30,
(in thousands of dollars)	2015			2014			2015			2014
Service cost	$	2,962		$	2,661		$	214		$	228
Interest cost	4,693			5,325			799			965
Expected return on plan assets	(7,153		)	(7,227		)	(30		)	(52		)
Curtailment gain	—			—			—			(1,503		)
Net amortization and deferral	2,398			1,560			(88		)	(266		)
Net periodic benefit cost	$	2,900		$	2,319		$	895		$	(628	)

XML

Fair Value Measurments (Narrative) (Details) - USD ($) $ in Millions	Sep. 30, 2015	Mar. 31, 2015	Sep. 30, 2014
Fair Value Disclosures [Abstract]
Long-term Obligations, Fair Value	$ 370	$ 370	$ 350

XML

Operating Segments (Tables)

6 Months Ended

Sep. 30, 2015

Segment Reporting [Abstract]

Operating Results For The Company's Reportable Segments

Operating results for the Company’s reportable segments for each period presented in the consolidated statements of income were as follows:

	Three Months Ended September 30,						Six Months Ended September 30,
(in thousands of dollars)	2015			2014			2015			2014
SALES AND OTHER OPERATING REVENUES
Flue-Cured and Burley Leaf Tobacco Operations:
North America	$	49,421		$	53,308		$	97,993		$	85,006
Other Regions (1)	371,032			371,669			548,433			569,241
Subtotal	420,453			424,977			646,426			654,247
Other Tobacco Operations (2)	35,929			39,139			85,375			81,341
Consolidated sales and other operating revenues	$	456,382		$	464,116		$	731,801		$	735,588
OPERATING INCOME
Flue-Cured and Burley Leaf Tobacco Operations:
North America	$	3,783		$	4,278		$	7,199		$	5,957
Other Regions (1)	34,202			21,661			26,355			11,086
Subtotal	37,985			25,939			33,554			17,043
Other Tobacco Operations (2)	145			2,640			1,053			3,900
Segment operating income	38,130			28,579			34,607			20,943
Deduct: Equity in pretax earnings of unconsolidated affiliates (3)	(846		)	(3,317		)	(230		)	(3,918		)
Restructuring and impairment costs (4)	—			(3,350		)	(2,389		)	(3,350		)
Consolidated operating income	$	37,284		$	21,912		$	31,988		$	13,675

⁽¹⁾  Includes South America, Africa, Europe, and Asia regions, as well as inter-region eliminations.

⁽²⁾  Includes Dark Air-Cured, Special Services, and Oriental, as well as inter-company eliminations. Sales and other operating revenues for this reportable segment include limited amounts for Oriental because its financial results consist principally of equity in the pretax earnings of an unconsolidated affiliate.

⁽³⁾  Equity in pretax earnings of unconsolidated affiliates is included in segment operating income (Other Tobacco Operations segment), but is reported below consolidated operating income and excluded from that total in the consolidated statements of income and comprehensive income.

⁽⁴⁾  Restructuring and impairment costs are excluded from segment operating income, but are included in consolidated operating income in the consolidated statements of income and comprehensive income.

XML

Accounting Pronouncements

6 Months Ended

Sep. 30, 2015

New Accounting Pronouncements and Changes in Accounting Principles [Abstract]

Accounting Pronouncements

ACCOUNTING PRONOUNCEMENTS

In May 2014, the Financial Accounting Standards Board ("FASB") issued Accounting Standards Update No. 2014-09, “Revenue from Contracts with Customers” (“ASU 2014-09”), which supersedes substantially all of the current revenue recognition guidance under U.S. generally accepted accounting principles (“U.S. GAAP”).  ASU 2014-09 was developed under a joint project with the International Accounting Standards Board (“IASB”) to improve and converge the existing revenue recognition accounting guidance in U.S. GAAP and International Accounting Standards.  Under ASU 2014-09, the central underlying principle is to recognize revenues when promised goods or services are transferred to customers at an amount determined by the consideration a company expects to receive for those goods or services.  The guidance outlines a five-step process for determining the amount and timing of revenue to be recognized from those arrangements.  It is more principles-based than the existing guidance under U.S. GAAP, and therefore is expected to require more management judgment and involve more estimates than the current guidance.  ASU 2014-09 is effective for annual periods beginning after December 15, 2017, including all interim periods within the year of adoption. Companies are allowed to select between two transition methods:  (1) a full retrospective transition method with the application of the new guidance to each prior reporting period presented, or (2) a retrospective transition method that recognizes the cumulative effect on prior periods at the date of adoption together with additional footnote disclosures.  Universal expects to adopt ASU 2014-09 effective April 1, 2018, which is the beginning of the fiscal year ending March 31, 2019.  The Company is currently evaluating the impact that the adoption of ASU 2014-09 will have on its consolidated financial statements and has not made any decision on the method of adoption.

In April 2015, the FASB issued Accounting Standards Update No. 2015-03, “Simplifying the Presentation of Debt Issuance Costs” (“ASU 2015-03”). ASU 2015-03 requires that debt issuance costs related to a recognized debt liability be presented in the balance sheet as a direct deduction from the carrying amount of that debt liability, consistent with debt discounts. ASU 2015-03 is effective for fiscal years beginning after December 31, 2015. The Company will make the required balance sheet presentation change upon adoption of ASU 2015-03 effective for the quarter ending June 30, 2016, which is the first quarter of the fiscal year ending March 31, 2017.

In July 2015, the FASB issued Accounting Standards Update No. 2015-11, “Simplifying the Measurement of Inventory” (“ASU 2015-11”). ASU 2015-11 requires that most inventory be measured at the lower of cost and net realizable value. ASU 2015-11 defines net realizable value as the "estimated selling price in the ordinary course of business, less reasonable predictable costs of completion, disposal, and transportation." ASU 2015-011 is effective for fiscal years beginning after December 31, 2016. The Company is currently evaluating the impact that the adoption of ASU 2015-11 will have on its consolidated financial statements. ASU 2015-11 will be applied prospectively after the date of adoption, as required by the guidance.

XML

Consolidated Balance Sheets - USD ($) $ in Thousands	Sep. 30, 2015	Mar. 31, 2015	Sep. 30, 2014
ASSETS
Cash and cash equivalents	$ 68,970	$ 248,783	$ 29,567
Accounts receivable, net	303,963	434,362	290,162
Advances to suppliers, net	40,627	114,883	70,296
Accounts receivable - unconsolidated affiliates	59,370	1,907	98,707
Inventories - at lower of cost or market:
Tobacco	999,312	636,488	1,164,293
Other	85,222	62,195	100,516
Prepaid income taxes	19,779	17,811	28,138
Deferred income taxes	31,491	36,611	34,560
Other current assets	75,122	81,570	83,754
Total current assets	1,683,856	1,634,610	1,899,993
Property, plant and equipment
Land	16,583	16,790	17,022
Buildings	252,153	238,372	239,568
Machinery and equipment	585,466	576,010	577,064
Total property, plant and equipment	854,202	831,172	833,654
Less: accumulated depreciation	(539,749)	(525,783)	(528,722)
Property, plant and equipment, net	314,453	305,389	304,932
Other assets
Goodwill and other intangibles	99,049	99,146	99,291
Investments in unconsolidated affiliates	79,995	76,512	88,841
Deferred income taxes	20,661	6,301	18,861
Other noncurrent assets	55,976	76,515	68,973
Total other assets	255,681	258,474	275,966
Total assets	2,253,990	2,198,473	2,480,891
LIABILITIES AND SHAREHOLDERS' EQUITY
Notes payable and overdrafts	86,095	59,862	359,349
Accounts payable and accrued expenses	155,824	140,112	154,826
Accounts payable - unconsolidated affiliates	98	3,281	1,150
Customer advances and deposits	67,100	30,183	57,723
Accrued compensation	18,423	28,232	20,272
Income taxes payable	5,612	9,243	11,164
Current portion of long-term obligations	0	0	118,750
Total current liabilities	333,152	270,913	723,234
Long-term obligations	370,000	370,000	230,000
Pensions and other postretirement benefits	93,588	97,048	74,975
Other long-term liabilities	37,472	36,790	34,567
Deferred income taxes	32,067	26,628	39,235
Total liabilities	866,279	801,379	1,102,011
Shareholders' equity
Common stock, no par value, 100,000,000 shares authorized, 22,680,233 shares issued and outstanding (23,183,259 at September 30, 2014, and 22,593,266 at March 31, 2015)	207,349	206,002	207,552
Retained earnings	1,005,353	1,020,155	971,391
Accumulated other comprehensive loss	(71,657)	(74,994)	(44,001)
Total Universal Corporation shareholders' equity	1,352,607	1,362,725	1,347,965
Noncontrolling interests in subsidiaries	35,104	34,369	30,915
Total shareholders' equity	1,387,711	1,397,094	1,378,880
Total liabilities and shareholders' equity	2,253,990	2,198,473	2,480,891
Series A Junior Participating Preferred Stock [Member]
Shareholders' equity
Preferred Stock	0	0	0
Series B 6.75% Convertible Perpetual Preferred Stock [Member]
Shareholders' equity
Preferred Stock	$ 211,562	$ 211,562	$ 213,023

XML

Accumulated Other Comprehensive Income (Loss) Accumulated Other Comprehensive Income (Loss)

6 Months Ended

Sep. 30, 2015

Accumulated Other Comprehensive Income (Loss), Net of Tax [Abstract]

Accumulated Other Comprehensive Income (Loss), Net of Tax

ACCUMULATED OTHER COMPREHENSIVE INCOME (LOSS)

The following table summarizes the changes in the accumulated balances for each component of accumulated other comprehensive income (loss) attributable to the Company for the six months ended September 30, 2015 and 2014:

	Six Months Ended September 30,
(in thousands of dollars)	2015			2014
Foreign currency translation:
Balance at beginning of year	$	(31,138	)	$	(8,476	)
Other comprehensive income (loss) attributable to Universal Corporation:
Net gain (loss) on foreign currency translation (net of tax (expense) benefit of $(1,155) and $4,921)	2,147			(9,138		)
Less: Net gain (loss) on foreign currency translation attributable to noncontrolling interests	426			(37		)
Other comprehensive income (loss) attributable to Universal Corporation, net of income taxes	2,573			(9,175		)
Balance at end of period	$	(28,565	)	$	(17,651	)
Foreign currency hedge:
Balance at beginning of year	$	(1,834	)	$	769
Other comprehensive income (loss) attributable to Universal Corporation:
Net gain (loss) on derivative instruments (net of tax (expense) benefit of $(878) and $571)	1,629			(1,060		)
Reclassification of gain to earnings (net of tax expense of $90 and $385)(1)	(166		)	(715		)
Other comprehensive income (loss) attributable to Universal Corporation, net of income taxes	1,463			(1,775		)
Balance at end of period	$	(371	)	$	(1,006	)
Interest rate hedge:
Balance at beginning of year	$	(1,982	)	$	(608	)
Other comprehensive income (loss) attributable to Universal Corporation:
Net loss on derivative instruments (net of tax benefit of $2,120 and $38)	(3,937		)	(69		)
Reclassification of loss to earnings (net of tax benefit of $(936) and $(142))(2)	1,740			263
Other comprehensive income (loss) attributable to Universal Corporation, net of income taxes	(2,197		)	194
Balance at end of period	$	(4,179	)	$	(414	)
Pension and other postretirement benefit plan:
Balance at beginning of year	$	(40,040	)	$	(26,017	)
Other comprehensive income (loss) attributable to Universal Corporation:
Amortization included in earnings (net of tax benefit of $(844) and $(550)) (3)	1,498			1,087
Other comprehensive income (loss) attributable to Universal Corporation, net of income taxes	1,498			1,087
Balance at end of period	$	(38,542	)	$	(24,930	)
Total accumulated other comprehensive income (loss) at end of period	$	(71,657	)	$	(44,001	)

⁽¹⁾ Gain (loss) on foreign currency cash flow hedges related to forecast purchases of tobacco is reclassified from accumulated other comprehensive income (loss) to cost of goods sold when the tobacco is sold to customers. See Note 7 for additional information.

⁽²⁾ Gain (loss) on interest rate cash flow hedges is reclassified from accumulated other comprehensive income (loss) to interest expense when the related interest payments are made on the debt or upon termination of the interest rate swap agreements prior to their scheduled maturity dates. See Note 7 for additional information.

⁽³⁾ This accumulated other comprehensive income (loss) component is included in the computation of net periodic benefit cost. See Note 9 for additional information.

XML

Document And Entity Information - shares	6 Months Ended
	Sep. 30, 2015	Oct. 30, 2015
Document And Entity Information [Abstract]
Document Type	10-Q
Amendment Flag	false
Document Period End Date	Sep. 30, 2015
Document Fiscal Year Focus	2016
Document Fiscal Period Focus	Q2
Entity Registrant Name	UNIVERSAL CORP /VA/
Entity Central Index Key	0000102037
Current Fiscal Year End Date	--03-31
Entity Filer Category	Large Accelerated Filer
Entity Common Stock, Shares Outstanding		22,717,448

XML

Changes In Shareholders' Equity And Noncontrolling Interests In Subsidiaries

6 Months Ended

Sep. 30, 2015

Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest [Abstract]

Changes In Shareholders' Equity And Noncontrolling Interests In Subsidiaries

CHANGES IN SHAREHOLDERS' EQUITY AND NONCONTROLLING INTERESTS IN SUBSIDIARIES

A reconciliation of the changes in Universal Corporation shareholders’ equity and noncontrolling interests in subsidiaries for the six months ended September 30, 2015 and 2014 is as follows:

	Six Months Ended September 30, 2015									Six Months Ended September 30, 2014
(in thousands of dollars)	Universal Corporation			Non-controlling Interests			Total			Universal Corporation			Non-controlling Interests			Total
Balance at beginning of year	$	1,362,725		$	34,369		$	1,397,094		$	1,378,230		$	32,662		$	1,410,892
Changes in common stock
Issuance of common stock	—			—			—			187			—			187
Repurchase of common stock	—			—			—			(1,143		)	—			(1,143		)
Accrual of stock-based compensation	3,020			—			3,020			3,755			—			3,755
Withholding of shares from stock-based compensation for grantee income taxes	(2,037		)	—			(2,037		)	(2,009		)	—			(2,009		)
Dividend equivalents on RSUs	364			—			364			316			—			316
Changes in retained earnings
Net income	16,518			2,421			18,939			15,742			267			16,009
Cash dividends declared
Series B 6.75% convertible perpetual preferred stock	(7,374		)	—			(7,374		)	(7,425		)	—			(7,425		)
Common stock	(23,582		)	—			(23,582		)	(23,644		)	—			(23,644		)
Repurchase of common stock	—			—			—			(6,059		)	—			(6,059		)
Dividend equivalents on RSUs	(364		)	—			(364		)	(316		)	—			(316		)
Other comprehensive income (loss)	3,337			(426		)	2,911			(9,669		)	(37		)	(9,706		)
Dividends paid to noncontrolling shareholders	—			(1,260		)	(1,260		)	—			(1,977		)	(1,977		)
Balance at end of period	$	1,352,607		$	35,104		$	1,387,711		$	1,347,965		$	30,915		$	1,378,880

XML

Consolidated Balance Sheets (Parenthetical) - shares	Sep. 30, 2015	Mar. 31, 2015	Sep. 30, 2014
Common Stock [Member]
Common stock, shares authorized	100,000,000	100,000,000	100,000,000
Common stock, shares issued	22,680,233	22,593,266	23,183,259
Common stock, shares outstanding	22,680,233	22,593,266	23,183,259
Series A Junior Participating Preferred Stock [Member]
Preferred stock, shares authorized	500,000	500,000	500,000
Preferred stock, shares issued	0	0	0
Preferred stock, shares outstanding	0	0	0
Series B 6.75% Convertible Perpetual Preferred Stock [Member]
Preferred stock, shares authorized	220,000	220,000	220,000
Preferred stock, shares issued	218,490	218,490	219,999
Preferred stock, shares outstanding	218,490	218,490	219,999

XML

Derivatives And Hedging Activities

6 Months Ended

Sep. 30, 2015

Derivative Instruments and Hedging Activities Disclosure [Abstract]

Derivatives And Hedging Activities

DERIVATIVES AND HEDGING ACTIVITIES

Universal is exposed to various risks in its worldwide operations and uses derivative financial instruments to manage two specific types of risks – interest rate risk and foreign currency exchange rate risk. Interest rate risk is managed by entering into interest rate swap agreements, and foreign currency exchange rate risk is managed by entering into forward foreign currency exchange contracts. However, the Company’s policy also permits other types of derivative instruments. In addition, foreign currency exchange rate risk is also managed through strategies that do not involve derivative instruments, such as using local borrowings and other approaches to minimize net monetary positions in non-functional currencies. The disclosures below provide additional information about the Company’s hedging strategies, the derivative instruments used, and the effects of these activities on the consolidated statements of income and the consolidated balance sheets. In the consolidated statements of cash flows, the cash flows associated with all of these activities are reported in net cash provided by operating activities.

Hedging Strategy for Interest Rate Risk

In January 2015, the Company entered into receive-floating/pay-fixed interest rate swap agreements that were designated and qualified as hedges of the exposure to changes in interest payment cash flows created by fluctuations in variable interest rates on two outstanding non-amortizing bank term loans that were funded as part of a new bank credit facility in December 2014. Although no significant ineffectiveness is expected with this hedging strategy, the effectiveness of the interest rate swaps is evaluated on a quarterly basis. At September 30, 2015, the total notional amount of the interest rate swaps was $370 million, which corresponded with the aggregate outstanding balance of the term loans.

Previously, the Company had receive-floating/pay-fixed interest rate swap agreements that were designated and qualified as cash flow hedges on an amortizing bank term loan that was repaid concurrent with closing on the new bank credit facility. Those swap agreements, which had an aggregate notional amount of approximately $74 million reflecting the principal balance outstanding on the loan, were terminated upon repayment of the debt in December 2014.

Cash Flow Hedging Strategy for Foreign Currency Exchange Rate Risk Related to Forecast Purchases of Tobacco and Related Processing Costs

The majority of the tobacco production in most countries outside the United States where Universal operates is sold in export markets at prices denominated in U.S. dollars. However, purchases of tobacco from farmers and most processing costs (such as labor and energy) in those countries are usually denominated in the local currency. Changes in exchange rates between the U.S. dollar and the local currencies where tobacco is grown and processed affect the ultimate U.S. dollar cost of the processed tobacco. From time to time, the Company enters into forward contracts to sell U.S. dollars and buy the local currency at future dates that coincide with the expected timing of a portion of the tobacco purchases and processing costs. This strategy offsets the variability of future U.S. dollar cash flows for tobacco purchases and processing costs for the foreign currency notional amount hedged. This hedging strategy has been used mainly for tobacco purchases and processing costs in Brazil. The aggregate U.S. dollar notional amount of forward contracts entered for these purposes during the first six months of fiscal years 2016 and 2015, was as follows:

	Six Months Ended September 30,
(in millions of dollars)	2015		2014
Tobacco purchases	$	19.8	$	53.8
Processing costs	5.6		12.3
Total	$	25.4	$	66.1

All contracts related to tobacco purchases were designated and qualify as hedges of the future cash flows associated with the forecast purchases of tobacco. As a result, except for amounts related to any ineffective portion of the hedging strategy or any early de-designation of the hedge arrangement, changes in fair values of the forward contracts have been recognized in comprehensive income as they occurred, but only recognized in earnings upon sale of the related tobacco to third-party customers. Forward contracts related to processing costs have not been designated as hedges, and gains and losses on those contracts have been recognized in earnings on a mark-to-market basis.

Purchases of the 2015 crop in Brazil were completed in August 2015, and all forward contracts to hedge those purchases matured and settled by that time. For substantially all hedge gains and losses recorded in accumulated other comprehensive loss at September 30, 2015, the Company expects to complete the sale of the tobacco and recognize the amounts in earnings during fiscal year 2016.

Hedging Strategy for Foreign Currency Exchange Rate Risk Related to Net Local Currency Monetary Assets and Liabilities of Foreign Subsidiaries

Most of the Company’s foreign subsidiaries transact the majority of their sales in U.S. dollars and finance the majority of their operating requirements with U.S. dollar borrowings, and therefore use the U.S. dollar as their functional currency. These subsidiaries normally have certain monetary assets and liabilities on their balance sheets that are denominated in the local currency. Those assets and liabilities can include cash and cash equivalents, accounts receivable and accounts payable, advances to farmers and suppliers, deferred income tax assets and liabilities, recoverable value-added taxes, and other items. Net monetary assets and liabilities denominated in the local currency are remeasured into U.S. dollars each reporting period, generating gains and losses that the Company records in earnings as a component of selling, general, and administrative expenses. The level of net monetary assets or liabilities denominated in the local currency normally fluctuates throughout the year based on the operating cycle, but it is most common for monetary assets to exceed monetary liabilities, sometimes by a significant amount. When this situation exists and the local currency weakens against the U.S. dollar, remeasurement losses are generated. Conversely, remeasurement gains are generated on a net monetary asset position when the local currency strengthens against the U.S. dollar. To manage a portion of its exposure to currency remeasurement gains and losses, the Company enters into forward contracts to buy or sell the local currency at future dates coinciding with expected changes in the overall net local currency monetary asset position of the subsidiary. Gains and losses on the forward contracts are recorded in earnings as a component of selling, general, and administrative expenses for each reporting period as they occur, and thus directly offset the related remeasurement losses or gains in the consolidated statements of income for the notional amount hedged. The Company does not designate these contracts as hedges for accounting purposes. The contracts are generally arranged to hedge the subsidiary's projected exposure to currency remeasurement risk for specified periods of time, and new contracts are entered as necessary throughout the year to replace previous contracts as they mature. The Company is currently using forward currency contracts to manage its exposure to currency remeasurement risk in Brazil. The total notional amounts of contracts outstanding at September 30, 2015 and 2014, and March 31, 2015, were approximately $114.0 million, $89.8 million, and $80.4 million, respectively. To further mitigate currency remeasurement exposure, the Company’s foreign subsidiaries may utilize short-term local currency financing during certain periods. This strategy, while not involving the use of derivative instruments, is intended to minimize the subsidiary’s net monetary position by financing a portion of the local currency monetary assets with local currency monetary liabilities and thus hedging a portion of the overall position.

Several of the Company’s foreign subsidiaries transact the majority of their sales and finance the majority of their operating requirements in their local currency, and therefore use their respective local currencies as the functional currency for reporting purposes. From time to time, these subsidiaries sell tobacco to customers in transactions that are not denominated in the functional currency. In those situations, the subsidiaries routinely enter into forward exchange contracts to offset currency risk for the period of time that a fixed-price order and the related trade account receivable are outstanding with the customer. The contracts are not designated as hedges for accounting purposes.

Effect of Derivative Financial Instruments on the Consolidated Statements of Income

The table below outlines the effects of the Company’s use of derivative financial instruments on the consolidated statements of income for the three- and six-month periods ended September 30, 2015 and 2014:

	Three Months Ended September 30,						Six Months Ended September 30,
(in thousands of dollars)	2015			2014			2015			2014
Cash Flow Hedges - Interest Rate Swap Agreements
Derivative
Effective Portion of Hedge
Gain (loss) recorded in accumulated other comprehensive loss	$	(9,732	)	$	50		$	(6,056	)	$	(109	)
Gain (loss) reclassified from accumulated other comprehensive loss into earnings	$	(1,341	)	$	(199	)	$	(2,676	)	$	(406	)
Location of gain (loss) reclassified from accumulated other comprehensive loss into earnings	Interest expense
Ineffective Portion of Hedge
Gain (loss) recognized in earnings	$	—		$	—		$	—		$	—
Location of gain (loss) recognized in earnings	Selling, general and administrative expenses
Hedged Item
Description of hedged item	Floating rate interest payments on term loan
Cash Flow Hedges - Forward Foreign Currency Exchange Contracts
Derivative
Effective Portion of Hedge
Gain (loss) recorded in accumulated other comprehensive loss	$	101		$	47		$	1,283		$	1,700
Gain (loss) reclassified from accumulated other comprehensive loss into earnings	$	344		$	1,208		$	358		$	1,459
Location of gain (loss) reclassified from accumulated other comprehensive loss into earnings	Cost of goods sold
Ineffective Portion and Early De-designation of Hedges
Gain (loss) recognized in earnings	$	(673	)	$	30		$	745		$	257
Location of gain (loss) recognized in earnings	Selling, general and administrative expenses
Hedged Item
Description of hedged item	Forecast purchases of tobacco in Brazil
Derivatives Not Designated as Hedges - Forward Foreign Currency Exchange Contracts
Gain (loss) recognized in earnings	$	10,524		$	4,176		$	8,380		$	2,881
Location of gain (loss) recognized in earnings	Selling, general and administrative expenses

For the interest rate swap agreements, the effective portion of the gain or loss on the derivative is recorded in accumulated other comprehensive loss and any ineffective portion is recorded in selling, general and administrative expenses. For the forward foreign currency exchange contracts designated as cash flow hedges of tobacco purchases in Brazil, a net hedge gain of approximately $0.6 million remained in accumulated other comprehensive loss at September 30, 2015. That balance reflects gains and losses on contracts related to the 2015 crop, less the amount reclassified to earnings related to tobacco sold through September 30, 2015. The majority of the balance in accumulated other comprehensive loss is expected to be recognized in earnings as a component of cost of goods sold in fiscal year 2016 as the related tobaccos are sold to customers. Based on the hedging strategy, as the gain or loss is recognized in earnings, it is expected to be offset by a change in the direct cost for the tobacco or by a change in sales prices if the strategy has been mandated by the customer. Generally, margins on the sale of the tobacco will not be significantly affected.

Effect of Derivative Financial Instruments on the Consolidated Balance Sheets

The table below outlines the effects of the Company’s derivative financial instruments on the consolidated balance sheets at September 30, 2015 and 2014, and March 31, 2015:

	Derivatives in a Fair Value Asset Position							Derivatives in a Fair Value Liability Position
	Balance Sheet Location	Fair Value as of						Balance Sheet Location	Fair Value as of
(in thousands of dollars)		Sept. 30, 2015		Sept. 30, 2014		March 31, 2015			Sept. 30, 2015		Sept. 30, 2014		March 31, 2015
Derivatives Designated as Hedging Instruments
Interest rate swap agreements	Other non-current assets	$	—	$	—	$	—	Other long-term liabilities	$	6,430	$	638	$	3,050
Forward foreign currency exchange contracts	Other current assets	—		—		106		Accounts payable and accrued expenses	—		—		396
Total		$	—	$	—	$	106		$	6,430	$	638	$	3,446
Derivatives Not Designated as Hedging Instruments
Forward foreign currency exchange contracts	Other current assets	$	4,354	$	5,172	$	5,148	Accounts payable and accrued expenses	$	12	$	109	$	183
Total		$	4,354	$	5,172	$	5,148		$	12	$	109	$	183

Substantially all of the Company's forward foreign exchange contracts are subject to master netting arrangements whereby the right to offset occurs in the event of default by a participating party. The Company has elected to present these contracts on a gross basis in the consolidated balance sheets.

XML

Income Taxes

6 Months Ended

Sep. 30, 2015

Income Tax Disclosure [Abstract]

Income Taxes

INCOME TAXES

The Company is subject to the tax laws of many jurisdictions. Changes in tax laws or the interpretation of tax laws can affect the Company’s earnings, as can the resolution of pending and contested tax issues. The Company's consolidated effective income tax rate on pretax earnings is affected by a number of factors, including the mix of domestic and foreign earnings, the effect of exchange rate changes on deferred taxes, and the Company’s ability to utilize foreign tax credits.

The consolidated effective income tax rate was approximately 27% for the quarter ended September 30, 2015, compared to 24% for the quarter ended September 30, 2014. The effective rate for both quarters was lower than the 35% U.S. federal statutory rate, primarily due to a lower effective tax rate on dividend income from unconsolidated operations, as well as the effect of changes in exchange rates on deferred income tax assets and liabilities of foreign subsidiaries. The reduction in the effective rate created by those items was more significant for the quarter ended September 30, 2014, primarily because pretax earnings were lower for that period.

The comparison of the consolidated effective income tax rates for the six-month periods ended September 30, 2015 and 2014 is affected by an income tax benefit of $8 million recorded in the prior year period, arising from the ability of a subsidiary to pay a significant portion of a fine and related interest charges that were settled during that period following the unsuccessful appeal of a case involving anti-competitive activities in the Italian tobacco market. Although the portion of the fine paid by the subsidiary was not deductible for income tax purposes in its local tax jurisdiction, it reduced the subsidiary’s cumulative undistributed earnings and the associated consolidated tax liability, resulting in the $8 million benefit in the Company’s consolidated income tax provision. Excluding this discrete item in the prior year, the consolidated effective income tax rate was 24% for the six months ended September 30, 2015, compared to 10% for the six months ended September 30, 2014. The effective tax rates for both periods benefited from the lower effective tax rate on dividend income from unconsolidated operations and from the effect of exchange rate changes on deferred income tax assets and liabilities; however, the effect of those items was more significant for the six months ended September 30, 2014 due to the lower pretax earnings for that period.

XML

Stock-Based Compensation (Tables)

6 Months Ended

Sep. 30, 2015

Share-based Compensation [Abstract]

Stock-Based Awards Issued During The Period

During the six-month periods ended September 30, 2015 and 2014, Universal issued the following stock-based awards, representing the regular annual grants to officers and outside directors of the Company:

	Six Months Ended September 30,
	2015		2014
RSUs:
Number granted	67,750		79,950
Grant date fair value	$	52.10	$	52.78
PSAs:
Number granted	57,750		48,450
Grant date fair value	$	45.06	$	46.41

XML

Earnings Per Share (Tables)

6 Months Ended

Sep. 30, 2015

Earnings Per Share [Abstract]

Schedule of Earnings Per Share, Basic and Diluted

The following table sets forth the computation of basic and diluted earnings per share:

	Three Months Ended September 30,						Six Months Ended September 30,
(in thousands, except share and per share data)	2015			2014			2015			2014
Basic Earnings Per Share
Numerator for basic earnings per share
Net income attributable to Universal Corporation	$	22,465		$	15,025		$	16,518		$	15,742
Less: Dividends on convertible perpetual preferred stock	(3,687		)	(3,713		)	(7,374		)	(7,425		)
Earnings available to Universal Corporation common shareholders for calculation of basic earnings per share	18,778			11,312			9,144			8,317
Denominator for basic earnings per share
Weighted average shares outstanding	22,675,323			23,178,082			22,649,270			23,200,589
Basic earnings per share	$	0.83		$	0.49		$	0.40		$	0.36
Diluted Earnings Per Share
Numerator for diluted earnings per share
Earnings available to Universal Corporation common shareholders	$	18,778		$	11,312		$	9,144		$	8,317
Add: Dividends on convertible perpetual preferred stock (if conversion assumed)	3,687			—			—			—
Earnings available to Universal Corporation common shareholders for calculation of diluted earnings per share	22,465			11,312			9,144			8,317
Denominator for diluted earnings per share
Weighted average shares outstanding	22,675,323			23,178,082			22,649,270			23,200,589
Effect of dilutive securities (if conversion or exercise assumed)
Convertible perpetual preferred stock	4,848,766			—			—			—
Employee share-based awards	326,539			330,445			287,361			320,982
Denominator for diluted earnings per share	27,850,628			23,508,527			22,936,631			23,521,571
Diluted earnings per share	$	0.81		$	0.48		$	0.40		$	0.35

Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share

For the six months ended September 30, 2015 and the three- and six-month periods ended September 30, 2014, conversion of the Company's outstanding Series B 6.75% Convertible Perpetual Preferred Stock was not assumed since the effects would have been antidilutive. The Company had the following potentially dilutive securities (stock appreciation rights) outstanding for the six months ended September 30, 2015 and 2014 that were not included in the computation of diluted earnings per share because their exercise price exceeded the market price of the Company's common stock, and thus their effect would have been antidilutive:

	Six Months Ended September 30,
	2015		2014
Potentially dilutive securities	133,600		169,000
Weighted-average exercise price	$	62.66	$	62.66

XML

Stock-Based Compensation

6 Months Ended

Sep. 30, 2015

Share-based Compensation [Abstract]

Stock-Based Compensation

STOCK-BASED COMPENSATION

Universal’s shareholders have approved Executive Stock Plans (“Plans”) under which officers, directors, and employees of the Company may receive grants and awards of common stock, restricted stock, restricted stock units (“RSUs”), performance share awards (“PSAs”), stock appreciation rights (“SARs”), incentive stock options, and non-qualified stock options. The Company’s practice is to award grants of stock-based compensation to officers on an annual basis at the first regularly-scheduled meeting of the Executive Compensation, Nominating and Corporate Governance Committee of the Board of Directors (the “Compensation Committee”) in the fiscal year following the public release of the Company’s financial results for the prior year. The Compensation Committee administers the Company’s Plans consistently, following previously defined guidelines. Awards of restricted stock, RSUs, PSAs, and SARs are currently outstanding under the Plans. The SARs have an exercise price equal to the closing price of a share of the Company's common stock on the grant date. They are settled in shares of common stock, vest in equal one-third tranches one, two, and three years after the grant date, and expire ten years after the grant date, except that SARs granted after fiscal year 2007 expire on the earlier of three years after the grantee’s retirement date or ten years after the grant date. The RSUs vest five years from the grant date and are then paid out in shares of common stock. Under the terms of the RSU awards, grantees receive dividend equivalents in the form of additional RSUs that vest and are paid out on the same date as the original RSU grant. The PSAs vest three years from the grant date, are paid out in shares of common stock at the vesting date, and do not carry rights to dividends or dividend equivalents prior to vesting. Shares ultimately paid out under PSA grants are dependent on the achievement of predetermined performance measures established by the Compensation Committee and can range from zero to 150% of the stated award. The Company’s outside directors automatically receive restricted stock units or shares of restricted stock following each annual meeting of shareholders. RSUs awarded to outside directors vest three years after the grant date, and restricted shares vest upon the individual’s retirement from service as a director.

During the six-month periods ended September 30, 2015 and 2014, Universal issued the following stock-based awards, representing the regular annual grants to officers and outside directors of the Company:

	Six Months Ended September 30,
	2015		2014
RSUs:
Number granted	67,750		79,950
Grant date fair value	$	52.10	$	52.78
PSAs:
Number granted	57,750		48,450
Grant date fair value	$	45.06	$	46.41

As indicated in the table above, the Compensation Committee awarded only grants of RSUs and PSAs in both the current and prior fiscal years, and did not award any other types of stock-based compensation.

Fair value expense for stock-based compensation is recognized ratably over the period from grant date to the earlier of: (1) the vesting date of the award, or (2) the date the grantee is eligible to retire without forfeiting the award. For employees who are already eligible to retire at the date an award is granted, the total fair value of all non-forfeitable awards is recognized as expense at the date of grant. As a result, Universal typically incurs higher stock compensation expense in the first quarter of each fiscal year when grants are awarded to officers than in the other three quarters. For PSAs, the Company generally recognizes fair value expense ratably over the performance and vesting period based on management’s judgment of the ultimate award that is likely to be paid out based on the achievement of the predetermined performance measures. For the six-month periods ended September 30, 2015 and 2014, the Company recorded total stock-based compensation expense of approximately $3.0 million and $3.8 million, respectively. The Company expects to recognize stock-based compensation expense of approximately $2.3 million during the remaining six months of fiscal year 2016.

XML

Fair Value Measurements

6 Months Ended

Sep. 30, 2015

Fair Value Disclosures [Abstract]

Fair Value Measurements

FAIR VALUE MEASUREMENTS

Universal measures certain financial and nonfinancial assets and liabilities at fair value based on applicable accounting guidance. The financial assets and liabilities measured at fair value include money market funds, trading securities associated with deferred compensation plans, interest rate swap agreements, forward foreign currency exchange contracts, and guarantees of bank loans to tobacco growers. The application of the fair value guidance to nonfinancial assets and liabilities primarily includes the determination of fair value for goodwill and long-lived assets when indicators of potential impairment are present.

Under the accounting guidance, fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. The framework for measuring fair value is based on a fair value hierarchy that distinguishes between observable inputs and unobservable inputs. Observable inputs are based on market data obtained from independent sources. Unobservable inputs require the Company to make its own assumptions about the value placed on an asset or liability by market participants because little or no market data exists. There are three levels within the fair value hierarchy:

Level	Description
1	quoted prices in active markets for identical assets or liabilities that the Company has the ability to access as of the reporting date;
2	quoted prices in active markets for similar assets or liabilities, or quoted prices for identical or similar assets or liabilities in markets that are not active, or inputs other than quoted prices that are observable for the asset or liability; and
3	unobservable inputs for the asset or liability.

In measuring the fair value of liabilities, the Company considers the risk of non-performance in determining fair value. Universal has not elected to report at fair value any financial instruments or any other assets or liabilities that are not required to be reported at fair value under current accounting guidance.

At September 30, 2015 and 2014, and at March 31, 2015, the Company had certain financial assets and financial liabilities that were required to be measured and reported at fair value on a recurring basis. These assets and liabilities are listed in the tables below and are classified based on how their values were determined under the fair value hierarchy:

	September 30, 2015
(in thousands of dollars)	Level 1		Level 2		Level 3		Total
Assets
Money market funds	$	—	$	1,574	$	—	$	1,574
Trading securities associated with deferred compensation plans	18,359		—		—		18,359
Forward foreign currency exchange contracts	—		4,354		—		4,354
Total financial assets measured and reported at fair value	$	18,359	$	5,928	$	—	$	24,287
Liabilities
Guarantees of bank loans to tobacco growers	$	—	$	—	$	1,356	$	1,356
Interest rate swap agreements	—		6,430		—		6,430
Forward foreign currency exchange contracts	—		13		—		13
Total financial liabilities measured and reported at fair value	$	—	$	6,443	$	1,356	$	7,799

	September 30, 2014
(in thousands of dollars)	Level 1		Level 2		Level 3		Total
Assets
Money market funds	$	—	$	1,527	$	—	$	1,527
Trading securities associated with deferred compensation plans	20,039		—		—		20,039
Forward foreign currency exchange contracts	—		5,172		—		5,172
Total financial assets measured and reported at fair value	$	20,039	$	6,699	$	—	$	26,738
Liabilities
Guarantees of bank loans to tobacco growers	$	—	$	—	$	1,797	$	1,797
Interest rate swap agreements	—		638		—		638
Forward foreign currency exchange contracts	—		109		—		109
Total financial liabilities measured and reported at fair value	$	—	$	747	$	1,797	$	2,544

	March 31, 2015
(in thousands of dollars)	Level 1		Level 2		Level 3		Total
Assets
Money market funds	$	—	$	86,552	$	—	$	86,552
Trading securities associated with deferred compensation plans	20,692		—		—		20,692
Forward foreign currency exchange contracts	—		5,254		—		5,254
Total financial assets measured and reported at fair value	$	20,692	$	91,806	$	—	$	112,498
Liabilities
Guarantees of bank loans to tobacco growers	$	—	$	—	$	1,674	$	1,674
Interest rate swap agreements	—		3,050		—		3,050
Forward foreign currency exchange contracts	—		579		—		579
Total financial liabilities measured and reported at fair value	$	—	$	3,629	$	1,674	$	5,303

Money market funds

The fair value of money market funds, which are reported in cash and cash equivalents in the consolidated balance sheets, is based on net asset value, which is computed based on amortized cost (Level 2). The fair values of these investments approximate cost due to the short-term maturities and the high credit quality of the issuers of the underlying securities.

Trading securities associated with deferred compensation plans

Trading securities represent mutual fund investments that are matched to employee deferred compensation obligations. These investments are bought and sold as employees defer compensation, receive distributions, or make changes in the funds underlying their accounts. Quoted market prices (Level 1) are used to determine the fair values of the mutual funds.

Interest rate swap agreements

The fair values of interest rate swap agreements are determined based on dealer quotes using a discounted cash flow model matched to the contractual terms of each instrument. Since inputs to the model are observable and significant judgment is not required in determining the fair values, interest rate swaps are classified within Level 2 of the fair value hierarchy.

Forward foreign currency exchange contracts

The fair values of forward foreign currency exchange contracts are also determined based on dealer quotes using a discounted cash flow model matched to the contractual terms of each instrument. Since inputs to the model are observable and significant judgment is not required in determining the fair values, forward foreign currency exchange contracts are classified within Level 2 of the fair value hierarchy.

Guarantees of bank loans to tobacco growers

The Company guarantees bank loans to tobacco growers in Brazil for crop financing and has previously guaranteed loans to those growers for the construction of curing barns or other tobacco producing assets. In the event that the farmers default on their payments to the banks, the Company would be required to perform under the guarantees. The Company regularly evaluates the likelihood of farmer defaults based on an expected loss analysis and records the fair value of its guarantees as an obligation in its consolidated financial statements. The fair value of the guarantees is determined using the expected loss data for all loans outstanding at each measurement date. The present value of the cash flows associated with the estimated losses is then calculated at a risk-adjusted interest rate that is aligned with the expected duration of the liability and includes an adjustment for nonperformance risk. This approach is sometimes referred to as the “contingent claims valuation method.” Although historical loss data is an observable input, significant judgment is required in applying this information to the portfolio of guaranteed loans outstanding at each measurement date and in selecting a risk-adjusted interest rate. Significant increases or decreases in the risk-adjusted interest rate may result in a significantly higher or lower fair value measurement. The guarantees of bank loans to tobacco growers are therefore classified within Level 3 of the fair value hierarchy.

A reconciliation of the change in the balance of the financial liability for guarantees of bank loans to tobacco growers (Level 3) for the six months ended September 30, 2015 and 2014 is provided below.

	Six Months Ended September 30,
(in thousands of dollars)	2015			2014
Balance at beginning of year	$	1,674		$	2,270
Payments under the guarantees and transfers to allowance for loss on direct loans to farmers (removal of prior crop year loans from portfolio)	(1,841		)	(2,392		)
Provision for loss or transfers from allowance for loss on direct loans to farmers (addition of current crop year loans)	1,821			2,022
Change in discount rate and estimated collection period	33			36
Currency remeasurement	(331		)	(139		)
Balance at end of period	$	1,356		$	1,797

Long-term Obligations

The fair value of the Company’s long-term obligations, including the current portion, was approximately $370 million at September 30, 2015, $350 million at September 30, 2014, and $370 million at March 31, 2015. The Company estimates the fair value of its long-term obligations using Level 2 inputs which are based upon quoted market prices for the same or similar issues or on the current interest rates available to the Company for debt of similar terms and maturities.

XML

Pension And Other Postretirement Benefit Plans

6 Months Ended

Sep. 30, 2015

Defined Benefit Pension Plans and Defined Benefit Postretirement Plans Disclosure [Abstract]

Pension and Other Postretirement Benefits Disclosure

PENSION AND OTHER POSTRETIREMENT BENEFIT PLANS

The Company sponsors several defined benefit pension plans covering U.S. salaried employees and certain foreign and other employee groups. These plans provide retirement benefits based primarily on employee compensation and years of service. The Company also sponsors defined benefit plans that provide postretirement health and life insurance benefits for eligible U.S. employees attaining specific age and service levels.

The components of the Company’s net periodic benefit cost were as follows:

	Pension Benefits						Other Postretirement Benefits
	Three Months Ended September 30,						Three Months Ended September 30,
(in thousands of dollars)	2015			2014			2015			2014
Service cost	$	1,479		$	1,327		$	106		$	114
Interest cost	2,347			2,656			392			481
Expected return on plan assets	(3,577		)	(3,535		)	(15		)	(26		)
Curtailment gain	—			—			—			(1,503		)
Net amortization and deferral	1,199			780			(44		)	(133		)
Net periodic benefit cost	$	1,448		$	1,228		$	439		$	(1,067	)

	Pension Benefits						Other Postretirement Benefits
	Six Months Ended September 30,						Six Months Ended September 30,
(in thousands of dollars)	2015			2014			2015			2014
Service cost	$	2,962		$	2,661		$	214		$	228
Interest cost	4,693			5,325			799			965
Expected return on plan assets	(7,153		)	(7,227		)	(30		)	(52		)
Curtailment gain	—			—			—			(1,503		)
Net amortization and deferral	2,398			1,560			(88		)	(266		)
Net periodic benefit cost	$	2,900		$	2,319		$	895		$	(628	)

The net periodic benefit cost for the Company's pension and other postretirement benefit plans has increased from the prior fiscal year, primarily reflecting actuarial losses from lower market discount rates applicable to the most recent actuarial measurement of benefit liabilities and from lower expected long-term asset returns due to changes made during fiscal year 2015 to move toward a liability-driven investment strategy for the assets in the Company's U.S. ERISA-regulated defined benefit pension plan. The curtailment gain reflected in the above table for the three and six months ended September 30, 2014 was attributable to the elimination of postretirement life insurance benefits for active U.S. employees.

During the six months ended September 30, 2015, the Company made contributions of approximately $3.8 million to its pension plans. Additional contributions of approximately $8.6 million are expected during the remaining six months of fiscal year 2016, including $2.7 million to the Company's ERISA-regulated U.S. plan and $5.9 million to its non-ERISA regulated and other plans.

XML

Operating Segments

6 Months Ended

Sep. 30, 2015

Segment Reporting [Abstract]

Operating Segments

OPERATING SEGMENTS

The principal approach used by management to evaluate the Company’s performance is by geographic region, although the dark air-cured and oriental tobacco businesses are each evaluated on the basis of their worldwide operations. The Company evaluates the performance of its segments based on operating income after allocated overhead expenses (excluding significant non-recurring charges or credits), plus equity in the pretax earnings of unconsolidated affiliates.

Operating results for the Company’s reportable segments for each period presented in the consolidated statements of income were as follows:

	Three Months Ended September 30,						Six Months Ended September 30,
(in thousands of dollars)	2015			2014			2015			2014
SALES AND OTHER OPERATING REVENUES
Flue-Cured and Burley Leaf Tobacco Operations:
North America	$	49,421		$	53,308		$	97,993		$	85,006
Other Regions (1)	371,032			371,669			548,433			569,241
Subtotal	420,453			424,977			646,426			654,247
Other Tobacco Operations (2)	35,929			39,139			85,375			81,341
Consolidated sales and other operating revenues	$	456,382		$	464,116		$	731,801		$	735,588
OPERATING INCOME
Flue-Cured and Burley Leaf Tobacco Operations:
North America	$	3,783		$	4,278		$	7,199		$	5,957
Other Regions (1)	34,202			21,661			26,355			11,086
Subtotal	37,985			25,939			33,554			17,043
Other Tobacco Operations (2)	145			2,640			1,053			3,900
Segment operating income	38,130			28,579			34,607			20,943
Deduct: Equity in pretax earnings of unconsolidated affiliates (3)	(846		)	(3,317		)	(230		)	(3,918		)
Restructuring and impairment costs (4)	—			(3,350		)	(2,389		)	(3,350		)
Consolidated operating income	$	37,284		$	21,912		$	31,988		$	13,675

⁽¹⁾  Includes South America, Africa, Europe, and Asia regions, as well as inter-region eliminations.

⁽²⁾  Includes Dark Air-Cured, Special Services, and Oriental, as well as inter-company eliminations. Sales and other operating revenues for this reportable segment include limited amounts for Oriental because its financial results consist principally of equity in the pretax earnings of an unconsolidated affiliate.

⁽³⁾  Equity in pretax earnings of unconsolidated affiliates is included in segment operating income (Other Tobacco Operations segment), but is reported below consolidated operating income and excluded from that total in the consolidated statements of income and comprehensive income.

⁽⁴⁾  Restructuring and impairment costs are excluded from segment operating income, but are included in consolidated operating income in the consolidated statements of income and comprehensive income.

XML

Derivatives And Hedging Activities (Effect Of Derivative Financial Instruments On The Consolidated Statements Of Income) (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Sep. 30, 2015	Sep. 30, 2014	Sep. 30, 2015	Sep. 30, 2014
Derivatives Designated As Hedges [Member] | Interest Rate Swap Agreements [Member] | Interest Expense [Member]
Derivative Instruments, Gain (Loss) [Line Items]
Gain (loss) recorded in accumulated other comprehensive loss	$ (9,732)	$ 50	$ (6,056)	$ (109)
Gain (loss) reclassified from accumulated other comprehensive loss into earnings	(1,341)	(199)	(2,676)	(406)
Derivatives Designated As Hedges [Member] | Interest Rate Swap Agreements [Member] | Selling, General And Administrative Expenses [Member]
Derivative Instruments, Gain (Loss) [Line Items]
Gain (loss) recognized in earnings from ineffective portion and early de-designation of cash flow hedges	0	0	0	0
Derivatives Designated As Hedges [Member] | Forward Foreign Currency Exchange Contracts [Member] | Cost Of Goods Sold [Member]
Derivative Instruments, Gain (Loss) [Line Items]
Gain (loss) recorded in accumulated other comprehensive loss	101	47	1,283	1,700
Gain (loss) reclassified from accumulated other comprehensive loss into earnings	344	1,208	358	1,459
Derivatives Designated As Hedges [Member] | Forward Foreign Currency Exchange Contracts [Member] | Selling, General And Administrative Expenses [Member]
Derivative Instruments, Gain (Loss) [Line Items]
Gain (loss) recognized in earnings from ineffective portion and early de-designation of cash flow hedges	(673)	30	745	257
Derivatives Not Designated As Hedges [Member] | Forward Foreign Currency Exchange Contracts [Member] | Selling, General And Administrative Expenses [Member]
Derivative Instruments, Gain (Loss) [Line Items]
Gain (loss) recognized in earnings	$ 10,524	$ 4,176	$ 8,380	$ 2,881

XML

Fair Value Measurements (Tables)

6 Months Ended

Sep. 30, 2015

Fair Value Disclosures [Abstract]

Financial Assets And Liabilities Measured At Fair Value On Recurring Basis

At September 30, 2015 and 2014, and at March 31, 2015, the Company had certain financial assets and financial liabilities that were required to be measured and reported at fair value on a recurring basis. These assets and liabilities are listed in the tables below and are classified based on how their values were determined under the fair value hierarchy:

	September 30, 2015
(in thousands of dollars)	Level 1		Level 2		Level 3		Total
Assets
Money market funds	$	—	$	1,574	$	—	$	1,574
Trading securities associated with deferred compensation plans	18,359		—		—		18,359
Forward foreign currency exchange contracts	—		4,354		—		4,354
Total financial assets measured and reported at fair value	$	18,359	$	5,928	$	—	$	24,287
Liabilities
Guarantees of bank loans to tobacco growers	$	—	$	—	$	1,356	$	1,356
Interest rate swap agreements	—		6,430		—		6,430
Forward foreign currency exchange contracts	—		13		—		13
Total financial liabilities measured and reported at fair value	$	—	$	6,443	$	1,356	$	7,799

	September 30, 2014
(in thousands of dollars)	Level 1		Level 2		Level 3		Total
Assets
Money market funds	$	—	$	1,527	$	—	$	1,527
Trading securities associated with deferred compensation plans	20,039		—		—		20,039
Forward foreign currency exchange contracts	—		5,172		—		5,172
Total financial assets measured and reported at fair value	$	20,039	$	6,699	$	—	$	26,738
Liabilities
Guarantees of bank loans to tobacco growers	$	—	$	—	$	1,797	$	1,797
Interest rate swap agreements	—		638		—		638
Forward foreign currency exchange contracts	—		109		—		109
Total financial liabilities measured and reported at fair value	$	—	$	747	$	1,797	$	2,544

	March 31, 2015
(in thousands of dollars)	Level 1		Level 2		Level 3		Total
Assets
Money market funds	$	—	$	86,552	$	—	$	86,552
Trading securities associated with deferred compensation plans	20,692		—		—		20,692
Forward foreign currency exchange contracts	—		5,254		—		5,254
Total financial assets measured and reported at fair value	$	20,692	$	91,806	$	—	$	112,498
Liabilities
Guarantees of bank loans to tobacco growers	$	—	$	—	$	1,674	$	1,674
Interest rate swap agreements	—		3,050		—		3,050
Forward foreign currency exchange contracts	—		579		—		579
Total financial liabilities measured and reported at fair value	$	—	$	3,629	$	1,674	$	5,303

Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation

A reconciliation of the change in the balance of the financial liability for guarantees of bank loans to tobacco growers (Level 3) for the six months ended September 30, 2015 and 2014 is provided below.

	Six Months Ended September 30,
(in thousands of dollars)	2015			2014
Balance at beginning of year	$	1,674		$	2,270
Payments under the guarantees and transfers to allowance for loss on direct loans to farmers (removal of prior crop year loans from portfolio)	(1,841		)	(2,392		)
Provision for loss or transfers from allowance for loss on direct loans to farmers (addition of current crop year loans)	1,821			2,022
Change in discount rate and estimated collection period	33			36
Currency remeasurement	(331		)	(139		)
Balance at end of period	$	1,356		$	1,797

XML

Changes In Shareholders' Equity And Noncontrolling Interests In Subsidiaries (Tables)

6 Months Ended

Sep. 30, 2015

Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest [Abstract]

Reconciliation Of Changes In Shareholders' Equity And Noncontrolling Interests In Subsidiaries

A reconciliation of the changes in Universal Corporation shareholders’ equity and noncontrolling interests in subsidiaries for the six months ended September 30, 2015 and 2014 is as follows:

	Six Months Ended September 30, 2015									Six Months Ended September 30, 2014
(in thousands of dollars)	Universal Corporation			Non-controlling Interests			Total			Universal Corporation			Non-controlling Interests			Total
Balance at beginning of year	$	1,362,725		$	34,369		$	1,397,094		$	1,378,230		$	32,662		$	1,410,892
Changes in common stock
Issuance of common stock	—			—			—			187			—			187
Repurchase of common stock	—			—			—			(1,143		)	—			(1,143		)
Accrual of stock-based compensation	3,020			—			3,020			3,755			—			3,755
Withholding of shares from stock-based compensation for grantee income taxes	(2,037		)	—			(2,037		)	(2,009		)	—			(2,009		)
Dividend equivalents on RSUs	364			—			364			316			—			316
Changes in retained earnings
Net income	16,518			2,421			18,939			15,742			267			16,009
Cash dividends declared
Series B 6.75% convertible perpetual preferred stock	(7,374		)	—			(7,374		)	(7,425		)	—			(7,425		)
Common stock	(23,582		)	—			(23,582		)	(23,644		)	—			(23,644		)
Repurchase of common stock	—			—			—			(6,059		)	—			(6,059		)
Dividend equivalents on RSUs	(364		)	—			(364		)	(316		)	—			(316		)
Other comprehensive income (loss)	3,337			(426		)	2,911			(9,669		)	(37		)	(9,706		)
Dividends paid to noncontrolling shareholders	—			(1,260		)	(1,260		)	—			(1,977		)	(1,977		)
Balance at end of period	$	1,352,607		$	35,104		$	1,387,711		$	1,347,965		$	30,915		$	1,378,880

XML

Stock-Based Compensation (Narrative) (Details) - USD ($) $ in Millions	6 Months Ended
	Sep. 30, 2015	Sep. 30, 2014
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock-based compensation expense	$ 3.0	$ 3.8
Expected stock based compensation for remaining fiscal year	$ 2.3
Stock Appreciation Rights (SARs) [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Description of award vesting rights for SARs	vest in equal one-third tranches one, two, and three years after the grant date
Expiration period following grant date	10 years
Restricted Stock Units (RSUs) [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Vesting period	5 years
Performance Share Awards (PSAs) [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Vesting period	3 years
Minimum [Member] | Performance Share Awards (PSAs) [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Percentage of award grant paid	0.00%
Maximum [Member] | Performance Share Awards (PSAs) [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Percentage of award grant paid	150.00%
Outside Directors [Member] | Restricted Stock Units (RSUs) [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Vesting period	3 years
Plans After Fiscal Two Thousand Seven [Member] | Stock Appreciation Rights (SARs) [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Expiration period following grant date	10 years
Expiration period following grantee retirement	3 years

XML

Consolidated Statements Of Cash Flows - USD ($) $ in Thousands		6 Months Ended
		Sep. 30, 2015	Sep. 30, 2014
CASH FLOWS FROM OPERATING ACTIVITIES:
Net income		$ 18,939	$ 16,009
Adjustments to reconcile net income to net cash used by operating activities:
Depreciation		18,362	17,298
Amortization		446	816
Net provision for losses (recoveries) on advances and guaranteed loans to suppliers		(4,354)	(2,497)
Foreign currency remeasurement loss (gain), net		21,981	7,156
Restructuring and impairment costs	[1]	2,389	3,350
Other, net		481	(9,470)
Changes in operating assets and liabilities, net		(202,046)	(386,404)
Net cash used by operating activities		(143,802)	(353,742)
CASH FLOWS FROM INVESTING ACTIVITIES:
Purchase of property, plant and equipment		(28,457)	(30,571)
Proceeds from sale of property, plant and equipment		1,155	983
Net cash used by investing activities		(27,302)	(29,588)
CASH FLOWS FROM FINANCING ACTIVITIES:
Issuance (repayment) of short-term debt, net		23,826	297,507
Repayment of long-term obligations		0	(7,500)
Dividends paid to noncontrolling interests		(1,260)	(1,977)
Issuance of common stock		0	187
Repurchase of common stock		0	(7,202)
Dividends paid on convertible perpetual preferred stock		(7,374)	(7,425)
Dividends paid on common stock		(23,536)	(23,661)
Net cash provided (used) by financing activities		(8,344)	249,929
Effect of exchange rate changes on cash		(365)	(564)
Net decrease in cash and cash equivalents		(179,813)	(133,965)
Cash and cash equivalents at beginning of year		248,783	163,532
Cash and cash equivalents at end of period		$ 68,970	$ 29,567

[1] Restructuring and impairment costs are excluded from segment operating income, but are included in consolidated operating income in the consolidated statements of income and comprehensive income.

XML

Earnings Per Share

6 Months Ended

Sep. 30, 2015

Earnings Per Share [Abstract]

Earnings Per Share

EARNINGS PER SHARE

The following table sets forth the computation of basic and diluted earnings per share:

	Three Months Ended September 30,						Six Months Ended September 30,
(in thousands, except share and per share data)	2015			2014			2015			2014
Basic Earnings Per Share
Numerator for basic earnings per share
Net income attributable to Universal Corporation	$	22,465		$	15,025		$	16,518		$	15,742
Less: Dividends on convertible perpetual preferred stock	(3,687		)	(3,713		)	(7,374		)	(7,425		)
Earnings available to Universal Corporation common shareholders for calculation of basic earnings per share	18,778			11,312			9,144			8,317
Denominator for basic earnings per share
Weighted average shares outstanding	22,675,323			23,178,082			22,649,270			23,200,589
Basic earnings per share	$	0.83		$	0.49		$	0.40		$	0.36
Diluted Earnings Per Share
Numerator for diluted earnings per share
Earnings available to Universal Corporation common shareholders	$	18,778		$	11,312		$	9,144		$	8,317
Add: Dividends on convertible perpetual preferred stock (if conversion assumed)	3,687			—			—			—
Earnings available to Universal Corporation common shareholders for calculation of diluted earnings per share	22,465			11,312			9,144			8,317
Denominator for diluted earnings per share
Weighted average shares outstanding	22,675,323			23,178,082			22,649,270			23,200,589
Effect of dilutive securities (if conversion or exercise assumed)
Convertible perpetual preferred stock	4,848,766			—			—			—
Employee share-based awards	326,539			330,445			287,361			320,982
Denominator for diluted earnings per share	27,850,628			23,508,527			22,936,631			23,521,571
Diluted earnings per share	$	0.81		$	0.48		$	0.40		$	0.35

For the six months ended September 30, 2015 and the three- and six-month periods ended September 30, 2014, conversion of the Company's outstanding Series B 6.75% Convertible Perpetual Preferred Stock was not assumed since the effects would have been antidilutive. The Company had the following potentially dilutive securities (stock appreciation rights) outstanding for the six months ended September 30, 2015 and 2014 that were not included in the computation of diluted earnings per share because their exercise price exceeded the market price of the Company's common stock, and thus their effect would have been antidilutive:

	Six Months Ended September 30,
	2015		2014
Potentially dilutive securities	133,600		169,000
Weighted-average exercise price	$	62.66	$	62.66

XML

Guarantees, Other Contingent Liabilities, And Other Matters (Narrative) (Details) - USD ($) $ in Thousands	6 Months Ended
	Sep. 30, 2015	Sep. 30, 2014	Mar. 31, 2015
Guarantees, Other Contingent Liabilities, and Other Matters [Line Items]
Company total exposure under guarantees	$ 25,000
Face amount of guarantee including unpaid accrued interest	26,000	$ 35,000	$ 17,000
Fair value of the guarantees	1,356	1,797	1,674
Other contingent liabilities	3,000
Advances to suppliers current and non-current	71,000	115,000	156,000
Valuation allowance amount related to advances to suppliers	27,000	38,000	35,000
Net provision for losses (recoveries) on advances and guaranteed loans to suppliers	(4,354)	(2,497)
Aggregate balance of recoverable value added tax credits	52,000	69,000	60,000
Valuation allowance on recoverable value added tax credits	21,000	$ 37,000	$ 23,000
Santa Catarina [Member]
Guarantees, Other Contingent Liabilities, and Other Matters [Line Items]
Brazil audit assessment for tax, penalties, and interest on recoverable value added tax credits	12,000
Reduced Brazil audit assessment for tax, penalties, and interest on recoverable value added tax credits	10,000
Santa Catarina [Member] | Minimum [Member]
Guarantees, Other Contingent Liabilities, and Other Matters [Line Items]
Estimate of possible loss on remaining VAT audit assessment	0
Santa Catarina [Member] | Maximum [Member]
Guarantees, Other Contingent Liabilities, and Other Matters [Line Items]
Estimate of possible loss on remaining VAT audit assessment	10,000
Parana [Member]
Guarantees, Other Contingent Liabilities, and Other Matters [Line Items]
Brazil audit assessment for tax, penalties, and interest on recoverable value added tax credits	14,000
Parana [Member] | Minimum [Member]
Guarantees, Other Contingent Liabilities, and Other Matters [Line Items]
Estimate of possible loss on remaining VAT audit assessment	0
Parana [Member] | Maximum [Member]
Guarantees, Other Contingent Liabilities, and Other Matters [Line Items]
Estimate of possible loss on remaining VAT audit assessment	$ 12,000

XML

Fair Value Measurements (Reconciliation Of Change In Balance Of Financial Liability For Guarantees Of Bank Loans To Tobacco Growers) (Details) - USD ($) $ in Thousands	6 Months Ended
	Sep. 30, 2015	Sep. 30, 2014
Fair Value Disclosures [Abstract]
Balance at beginning of year	$ 1,674	$ 2,270
Payments under the guarantees and transfers to allowance for loss on direct loans to farmers (removal of prior crop year loans from portfolio)	(1,841)	(2,392)
Provision for loss or transfers from allowance for loss on direct loans to farmers (addition of current crop year loans)	1,821	2,022
Change in discount rate and estimated collection period	33	36
Currency remeasurement	(331)	(139)
Balance at end of period	$ 1,356	$ 1,797

XML

Derivatives And Hedging Activities (Tables)

6 Months Ended

Sep. 30, 2015

Derivative Instruments and Hedging Activities Disclosure [Abstract]

Notional Amount of Forward Contracts

The aggregate U.S. dollar notional amount of forward contracts entered for these purposes during the first six months of fiscal years 2016 and 2015, was as follows:

	Six Months Ended September 30,
(in millions of dollars)	2015		2014
Tobacco purchases	$	19.8	$	53.8
Processing costs	5.6		12.3
Total	$	25.4	$	66.1

Effect Of Derivative Financial Instruments On The Consolidated Statements Of Income

The table below outlines the effects of the Company’s use of derivative financial instruments on the consolidated statements of income for the three- and six-month periods ended September 30, 2015 and 2014:

	Three Months Ended September 30,						Six Months Ended September 30,
(in thousands of dollars)	2015			2014			2015			2014
Cash Flow Hedges - Interest Rate Swap Agreements
Derivative
Effective Portion of Hedge
Gain (loss) recorded in accumulated other comprehensive loss	$	(9,732	)	$	50		$	(6,056	)	$	(109	)
Gain (loss) reclassified from accumulated other comprehensive loss into earnings	$	(1,341	)	$	(199	)	$	(2,676	)	$	(406	)
Location of gain (loss) reclassified from accumulated other comprehensive loss into earnings	Interest expense
Ineffective Portion of Hedge
Gain (loss) recognized in earnings	$	—		$	—		$	—		$	—
Location of gain (loss) recognized in earnings	Selling, general and administrative expenses
Hedged Item
Description of hedged item	Floating rate interest payments on term loan
Cash Flow Hedges - Forward Foreign Currency Exchange Contracts
Derivative
Effective Portion of Hedge
Gain (loss) recorded in accumulated other comprehensive loss	$	101		$	47		$	1,283		$	1,700
Gain (loss) reclassified from accumulated other comprehensive loss into earnings	$	344		$	1,208		$	358		$	1,459
Location of gain (loss) reclassified from accumulated other comprehensive loss into earnings	Cost of goods sold
Ineffective Portion and Early De-designation of Hedges
Gain (loss) recognized in earnings	$	(673	)	$	30		$	745		$	257
Location of gain (loss) recognized in earnings	Selling, general and administrative expenses
Hedged Item
Description of hedged item	Forecast purchases of tobacco in Brazil
Derivatives Not Designated as Hedges - Forward Foreign Currency Exchange Contracts
Gain (loss) recognized in earnings	$	10,524		$	4,176		$	8,380		$	2,881
Location of gain (loss) recognized in earnings	Selling, general and administrative expenses

Effect Of Derivative Financial Instruments On The Consolidated Balance Sheets

The table below outlines the effects of the Company’s derivative financial instruments on the consolidated balance sheets at September 30, 2015 and 2014, and March 31, 2015:

	Derivatives in a Fair Value Asset Position							Derivatives in a Fair Value Liability Position
	Balance Sheet Location	Fair Value as of						Balance Sheet Location	Fair Value as of
(in thousands of dollars)		Sept. 30, 2015		Sept. 30, 2014		March 31, 2015			Sept. 30, 2015		Sept. 30, 2014		March 31, 2015
Derivatives Designated as Hedging Instruments
Interest rate swap agreements	Other non-current assets	$	—	$	—	$	—	Other long-term liabilities	$	6,430	$	638	$	3,050
Forward foreign currency exchange contracts	Other current assets	—		—		106		Accounts payable and accrued expenses	—		—		396
Total		$	—	$	—	$	106		$	6,430	$	638	$	3,446
Derivatives Not Designated as Hedging Instruments
Forward foreign currency exchange contracts	Other current assets	$	4,354	$	5,172	$	5,148	Accounts payable and accrued expenses	$	12	$	109	$	183
Total		$	4,354	$	5,172	$	5,148		$	12	$	109	$	183